<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>KQ4</title>

<script src="site_libs/header-attrs-2.11/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.11.4/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-9.12.0/textmate.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>
<script src="site_libs/kePrint-0.0.1/kePrint.js"></script>
<link href="site_libs/lightable-0.0.1/lightable.css" rel="stylesheet" />

<link rel="icon" href="https://github.com/workflowr/workflowr-assets/raw/main/img/reproducible.png">
<!-- Add a small amount of space between sections. -->
<style type="text/css">
div.section {
  padding-top: 12px;
}
</style>



<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>




<style type="text/css">
/* for pandoc --citeproc since 2.11 */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>




<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark it active
  menuAnchor.tab('show');

  // if it's got a parent navbar menu mark it active as well
  menuAnchor.closest('li.dropdown').addClass('active');

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "&#xe258;";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">NMB</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="soe.html">Strength of Evidence</a>
</li>
<li>
  <a href="kq1.html">NMM Technical</a>
</li>
<li>
  <a href="kq2.html">NMM Diagnostic</a>
</li>
<li>
  <a href="kq3.html">NMM Outcomes</a>
</li>
<li>
  <a href="reversal.html">Reversal</a>
</li>
<li>
  <a href="evidence_tables.html">Evidence Tables</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Appendices
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="prisma.html">PRISMA</a>
    </li>
    <li>
      <a href="outcome_importance.html">Outcome Importance</a>
    </li>
  </ul>
</li>
<li>
  <a href="about.html">About</a>
</li>
<li>
  <a href="license.html">License</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">KQ4</h1>
<h4 class="date">12 January, 2022 (17:34)</h4>

</div>


<p>
<button type="button" class="btn btn-default btn-workflowr btn-workflowr-report" data-toggle="collapse" data-target="#workflowr-report">
<span class="glyphicon glyphicon-list" aria-hidden="true"></span> workflowr <span class="glyphicon glyphicon-exclamation-sign text-danger" aria-hidden="true"></span>
</button>
</p>
<div id="workflowr-report" class="collapse">
<ul class="nav nav-tabs">
<li class="active">
<a data-toggle="tab" href="#summary">Summary</a>
</li>
<li>
<a data-toggle="tab" href="#checks"> Checks <span class="glyphicon glyphicon-exclamation-sign text-danger" aria-hidden="true"></span> </a>
</li>
<li>
<a data-toggle="tab" href="#versions">Past versions</a>
</li>
</ul>
<div class="tab-content">
<div id="summary" class="tab-pane fade in active">
<p>
<strong>Last updated:</strong> 2022-01-12
</p>
<p>
<strong>Checks:</strong> <span class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span> 6 <span class="glyphicon glyphicon-exclamation-sign text-danger" aria-hidden="true"></span> 1
</p>
<p>
<strong>Knit directory:</strong> <code>nmb/</code> <span class="glyphicon glyphicon-question-sign" aria-hidden="true" title="This is the local directory in which the code in this file was executed."> </span>
</p>
<p>
This reproducible <a href="https://rmarkdown.rstudio.com">R Markdown</a> analysis was created with <a
  href="https://github.com/workflowr/workflowr">workflowr</a> (version 1.7.0). The <em>Checks</em> tab describes the reproducibility checks that were applied when the results were created. The <em>Past versions</em> tab lists the development history.
</p>
<hr>
</div>
<div id="checks" class="tab-pane fade">
<div id="workflowr-checks" class="panel-group">
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongRMarkdownfilestronguncommittedchanges"> <span class="glyphicon glyphicon-exclamation-sign text-danger" aria-hidden="true"></span> <strong>R Markdown file:</strong> uncommitted changes </a>
</p>
</div>
<div id="strongRMarkdownfilestronguncommittedchanges" class="panel-collapse collapse">
<div class="panel-body">
<p>The R Markdown file has unstaged changes. To know which version of the R Markdown file created these results, you’ll want to first commit it to the Git repo. If you’re still working on the analysis, you can ignore this warning. When you’re finished, you can run <code>wflow_publish</code> to commit the R Markdown file and build the HTML.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongEnvironmentstrongempty"> <span class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span> <strong>Environment:</strong> empty </a>
</p>
</div>
<div id="strongEnvironmentstrongempty" class="panel-collapse collapse">
<div class="panel-body">
<p>Great job! The global environment was empty. Objects defined in the global environment can affect the analysis in your R Markdown file in unknown ways. For reproduciblity it’s best to always run the code in an empty environment.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongSeedstrongcodesetseed20211025code"> <span class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span> <strong>Seed:</strong> <code>set.seed(20211025)</code> </a>
</p>
</div>
<div id="strongSeedstrongcodesetseed20211025code" class="panel-collapse collapse">
<div class="panel-body">
<p>The command <code>set.seed(20211025)</code> was run prior to running the code in the R Markdown file. Setting a seed ensures that any results that rely on randomness, e.g. subsampling or permutations, are reproducible.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongSessioninformationstrongrecorded"> <span class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span> <strong>Session information:</strong> recorded </a>
</p>
</div>
<div id="strongSessioninformationstrongrecorded" class="panel-collapse collapse">
<div class="panel-body">
<p>Great job! Recording the operating system, R version, and package versions is critical for reproducibility.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongCachestrongnone"> <span class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span> <strong>Cache:</strong> none </a>
</p>
</div>
<div id="strongCachestrongnone" class="panel-collapse collapse">
<div class="panel-body">
<p>Nice! There were no cached chunks for this analysis, so you can be confident that you successfully produced the results during this run.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongFilepathsstrongrelative"> <span class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span> <strong>File paths:</strong> relative </a>
</p>
</div>
<div id="strongFilepathsstrongrelative" class="panel-collapse collapse">
<div class="panel-body">
<p>Great job! Using relative paths to the files within your workflowr project makes it easier to run your code on other machines.</p>
</div>
</div>
</div>
<div class="panel panel-default">
<div class="panel-heading">
<p class="panel-title">
<a data-toggle="collapse" data-parent="#workflowr-checks" href="#strongRepositoryversionstrongahrefhttpsgithubcommdgrantNMBtreeee9df67744de661cde5e21dc0714ec1cac38792etargetblankee9df67a"> <span class="glyphicon glyphicon-ok text-success" aria-hidden="true"></span> <strong>Repository version:</strong> <a href="https://github.com/mdgrant/NMB/tree/ee9df67744de661cde5e21dc0714ec1cac38792e" target="_blank">ee9df67</a> </a>
</p>
</div>
<div id="strongRepositoryversionstrongahrefhttpsgithubcommdgrantNMBtreeee9df67744de661cde5e21dc0714ec1cac38792etargetblankee9df67a" class="panel-collapse collapse">
<div class="panel-body">
<p>
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
</p>
<p>
The results in this page were generated with repository version <a href="https://github.com/mdgrant/NMB/tree/ee9df67744de661cde5e21dc0714ec1cac38792e" target="_blank">ee9df67</a>. See the <em>Past versions</em> tab to see a history of the changes made to the R Markdown and HTML files.
</p>
<p>
Note that you need to be careful to ensure that all relevant files for the analysis have been committed to Git prior to generating the results (you can use <code>wflow_publish</code> or <code>wflow_git_commit</code>). workflowr only checks the R Markdown file, but you know if there are other scripts or data files that it depends on. Below is the status of the Git repository when the results were generated:
</p>
<pre><code>
Ignored files:
    Ignored:    .DS_Store
    Ignored:    .Rhistory
    Ignored:    .Rproj.user/
    Ignored:    _@@/
    Ignored:    analysis/index (original).Rmd
    Ignored:    analysis/kq2 (original 2).Rmd
    Ignored:    code/helpers.R
    Ignored:    code/rob_summary.R
    Ignored:    code/rob_traffic_light.R
    Ignored:    code/rob_traffic_light_mg.R
    Ignored:    used_files_dates.txt
    Ignored:    used_rob_files_dates.txt

Untracked files:
    Untracked:  .temp.lb
    Untracked:  analysis/.gitignore
    Untracked:  code/.gitignore
    Untracked:  code/misc_calcs.R
    Untracked:  code/rob_111921 (original).R
    Untracked:  code/rob_111921.R
    Untracked:  code/rob_summary_mg.R
    Untracked:  data/

Unstaged changes:
    Modified:   analysis/evidence_tables.Rmd
    Modified:   analysis/kq1.Rmd
    Modified:   analysis/reversal.Rmd
    Modified:   code/readfiles_nmb_102721.R

</code></pre>
<p>
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
</p>
</div>
</div>
</div>
</div>
<hr>
</div>
<div id="versions" class="tab-pane fade">

<p>
These are the previous versions of the repository in which changes were made to the R Markdown (<code>analysis/reversal.Rmd</code>) and HTML (<code>docs/reversal.html</code>) files. If you’ve configured a remote Git repository (see <code>?wflow_git_remote</code>), click on the hyperlinks in the table below to view the files as they were in that past version.
</p>
<div class="table-responsive">
<table class="table table-condensed table-hover">
<thead>
<tr>
<th>
File
</th>
<th>
Version
</th>
<th>
Author
</th>
<th>
Date
</th>
<th>
Message
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/mdgrant/NMB/blob/c1442f39e00491658712849feb9ca7a8dbcb5975/analysis/reversal.Rmd" target="_blank">c1442f3</a>
</td>
<td>
Mark Grant
</td>
<td>
2022-01-12
</td>
<td>
reversal updates
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/c1442f39e00491658712849feb9ca7a8dbcb5975/docs/reversal.html" target="_blank">c1442f3</a>
</td>
<td>
Mark Grant
</td>
<td>
2022-01-12
</td>
<td>
reversal updates
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/db300b847fefdd363b2bb22a070fbc0bf99ddd82/docs/reversal.html" target="_blank">db300b8</a>
</td>
<td>
Mark Grant
</td>
<td>
2022-01-11
</td>
<td>
update evidence tables kq1, initial reversal
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/a99c6db3826fd0e9859dc2f36545c9f7bbc45aff/docs/reversal.html" target="_blank">a99c6db</a>
</td>
<td>
Mark Grant
</td>
<td>
2022-01-10
</td>
<td>
reversal updates draft
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/c73769aaee9c519dc51eeb29224d77b7a43ff7e2/docs/reversal.html" target="_blank">c73769a</a>
</td>
<td>
Mark Grant
</td>
<td>
2022-01-10
</td>
<td>
add rob rnmb
</td>
</tr>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/mdgrant/NMB/blob/9d6453a293772bbdf637e31441613aefa3b49e96/analysis/reversal.Rmd" target="_blank">9d6453a</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-12-30
</td>
<td>
updates to kq2 kq3
</td>
</tr>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/mdgrant/NMB/blob/eb4480d461d284dcf6ed089b843af68b32ec9608/analysis/reversal.Rmd" target="_blank">eb4480d</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-12-23
</td>
<td>
update reversal studies
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/eb4480d461d284dcf6ed089b843af68b32ec9608/docs/reversal.html" target="_blank">eb4480d</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-12-23
</td>
<td>
update reversal studies
</td>
</tr>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/mdgrant/NMB/blob/c467a0347451c3ce40b596b3147e615493e0de1d/analysis/reversal.Rmd" target="_blank">c467a03</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-21
</td>
<td>
misc fixes &amp; bib
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/c467a0347451c3ce40b596b3147e615493e0de1d/docs/reversal.html" target="_blank">c467a03</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-21
</td>
<td>
misc fixes &amp; bib
</td>
</tr>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/mdgrant/NMB/blob/334af0c3a551e16bb4f317738229140c13097019/analysis/reversal.Rmd" target="_blank">334af0c</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-17
</td>
<td>
remove footnote
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/334af0c3a551e16bb4f317738229140c13097019/docs/reversal.html" target="_blank">334af0c</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-17
</td>
<td>
remove footnote
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/ff838bd68936b6a5a7ba4ab701dab7238e289e47/docs/reversal.html" target="_blank">ff838bd</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-17
</td>
<td>
trying to fix reversal menu
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/2623a72bc5a9d11d514091f007f6aac8d1531674/docs/reversal.html" target="_blank">2623a72</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-17
</td>
<td>
try fix reversal
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/22d871bc3d33eae40ca0529a22396142b2072a13/docs/reversal.html" target="_blank">22d871b</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-17
</td>
<td>
update yml
</td>
</tr>
<tr>
<td>
Rmd
</td>
<td>
<a href="https://github.com/mdgrant/NMB/blob/0b12ae6adebb9e1ce8f9fa636557a5a3f2c77b47/analysis/reversal.Rmd" target="_blank">0b12ae6</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-17
</td>
<td>
add missing files
</td>
</tr>
<tr>
<td>
html
</td>
<td>
<a href="https://rawcdn.githack.com/mdgrant/NMB/0b12ae6adebb9e1ce8f9fa636557a5a3f2c77b47/docs/reversal.html" target="_blank">0b12ae6</a>
</td>
<td>
Mark Grant
</td>
<td>
2021-11-17
</td>
<td>
add missing files
</td>
</tr>
</tbody>
</table>
</div>
<hr>
</div>
</div>
</div>
<style type="text/css">
  body{
  font-size: 9.5pt;
  font-family: Source Sans Pro;
}

.caption {
  font-size: 15px;
}

.list-group-item.active, .list-group-item.active:hover, .list-group-item.active:focus {
  color: #090909;
  background-color: #0909093d;
}

.lightable-classic.lightable-hover tbody tr:hover {
    background-color: #c5d4e4;
}
.btn-xs, .btn-group-xs>.btn { 
display: none; 
}

.btn-default {
display: none !important; 
}

<!-- :target {  /* fix target location so caption appears */ -->
<!--     display: block;     -->
<!--     position: relative;      -->
<!--     top: 10px; -->
<!--     visibility: hidden; -->
<!-- } -->

</style>
<div id="included-studies" class="section level1">
<h1><strong>Included Studies</strong></h1>
<p><font size = 4> Table 1. Number of included studies according to age and design. </font></p>
<table class="table table-striped table-hover table-condensed lightable-classic lightable-hover" style=" font-family: Source Sans Pro; width: auto !important; border-bottom: 0;">
<thead>
<tr>
<th style="text-align:left;font-weight: bold;">
Age
</th>
<th style="text-align:left;font-weight: bold;">
Design
</th>
<th style="text-align:right;font-weight: bold;">
N
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;width: 8em; ">
Adult
</td>
<td style="text-align:left;width: 10em; ">
RCT
</td>
<td style="text-align:right;width: 3em; ">
105
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
</td>
<td style="text-align:left;width: 10em; ">
Quasi-Experimental
</td>
<td style="text-align:right;width: 3em; ">
1
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
</td>
<td style="text-align:left;width: 10em; ">
Nonrandomized
</td>
<td style="text-align:right;width: 3em; ">
8
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
</td>
<td style="text-align:left;width: 10em; ">
Prospective Cohort
</td>
<td style="text-align:right;width: 3em; ">
12
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
</td>
<td style="text-align:left;width: 10em; ">
Retrospective Cohort
</td>
<td style="text-align:right;width: 3em; ">
10
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
All ages
</td>
<td style="text-align:left;width: 10em; ">
RCT
</td>
<td style="text-align:right;width: 3em; ">
4
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
</td>
<td style="text-align:left;width: 10em; ">
Retrospective Cohort
</td>
<td style="text-align:right;width: 3em; ">
1
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
Pediatric
</td>
<td style="text-align:left;width: 10em; ">
RCT
</td>
<td style="text-align:right;width: 3em; ">
12
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
</td>
<td style="text-align:left;width: 10em; ">
Prospective Cohort
</td>
<td style="text-align:right;width: 3em; ">
4
</td>
</tr>
<tr>
<td style="text-align:left;width: 8em; ">
</td>
<td style="text-align:left;width: 10em; ">
Case-Control
</td>
<td style="text-align:right;width: 3em; ">
1
</td>
</tr>
<tr>
<td style="text-align:left;font-weight: bold;width: 8em; ">
Total
</td>
<td style="text-align:left;font-weight: bold;width: 10em; ">
</td>
<td style="text-align:right;font-weight: bold;width: 3em; ">
158
</td>
</tr>
</tbody>
<tfoot>
<tr>
<td style="padding: 0; " colspan="100%">
<sup></sup> RCT: randomized controlled trial.
</td>
</tr>
</tfoot>
</table>
<p><br/></p>
<div id="design-centers-country-surgery" class="section level2">
<h2><em>Design, centers, country, surgery</em></h2>
<p><br/></p>
<p><font size = 4> Table 2. Currently abstracted studies, design, enrollment, centers, country, and surgery (see <a href="#references">References</a> for citations). </font></p>
<table class="table table-striped table-hover table-condensed lightable-classic lightable-hover" style=" font-family: Source Sans Pro; width: auto !important; border-bottom: 0;">
<thead>
<tr>
<th style="text-align:left;font-weight: bold;">
            ID
</th>
<th style="text-align:left;font-weight: bold;">
Study
</th>
<th style="text-align:center;font-weight: bold;">
Analyzed (N)
</th>
<th style="text-align:center;font-weight: bold;">
Centers
</th>
<th style="text-align:left;font-weight: bold;">
Country<sup>a</sup>
</th>
<th style="text-align:left;font-weight: bold;">
Surgery
</th>
</tr>
</thead>
<tbody>
<tr grouplength="135">
<td colspan="6" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>Adult</strong>
</td>
</tr>
<tr grouplength="104">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
RCT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
121
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#121">Goldhill 1991</a>
</td>
<td style="text-align:center;width: 6em; ">
35
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
UK
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
414
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#414">Baurain 1994</a>
</td>
<td style="text-align:center;width: 6em; ">
24
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Belgium
</td>
<td style="text-align:left;width: 12em; ">
Gen
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
418
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#418">Boeke 1994</a>
</td>
<td style="text-align:center;width: 6em; ">
80
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Netherlands
</td>
<td style="text-align:left;width: 12em; ">
Gen
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
472
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#472">Maddineni 1994</a>
</td>
<td style="text-align:center;width: 6em; ">
20
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Ireland
</td>
<td style="text-align:left;width: 12em; ">
Gen, Ortho
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
604
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#604">Gyermek 1995</a>
</td>
<td style="text-align:center;width: 6em; ">
32
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
719
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#719">Trevien 1995</a>
</td>
<td style="text-align:center;width: 6em; ">
45
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
France
</td>
<td style="text-align:left;width: 12em; ">
Ortho
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
781
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#781">Kao 1996</a>
</td>
<td style="text-align:center;width: 6em; ">
30
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Ortho, Plastic
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
924
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#924">Hovorka 1997</a>
</td>
<td style="text-align:center;width: 6em; ">
160
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Finland
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Abdominal
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1034
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1034">Carroll 1998</a>
</td>
<td style="text-align:center;width: 6em; ">
30
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Ireland
</td>
<td style="text-align:left;width: 12em; ">
Ortho, ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1081
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1081">Nelskyla 1998</a>
</td>
<td style="text-align:center;width: 6em; ">
98
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Finland
</td>
<td style="text-align:left;width: 12em; ">
Gyn
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1155
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1155">Fuchs-Buder 1999</a>
</td>
<td style="text-align:center;width: 6em; ">
48
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Switzerland
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1188
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1188">Lien 1999</a>
</td>
<td style="text-align:center;width: 6em; ">
16
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1199
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1199">McCourt 1999</a>
</td>
<td style="text-align:center;width: 6em; ">
88
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:left;width: 10em; ">
Ireland
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1282
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1282">Hayes 2000</a>
</td>
<td style="text-align:center;width: 6em; ">
45
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Ireland
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1414
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1414">Lovstad 2001</a>
</td>
<td style="text-align:center;width: 6em; ">
88
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Norway
</td>
<td style="text-align:left;width: 12em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1511
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1511">Kirkegaard 2002</a>
</td>
<td style="text-align:center;width: 6em; ">
64
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1850
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1850">Adamus 2006</a>
</td>
<td style="text-align:center;width: 6em; ">
120
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Czech Republic
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1917
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1917">Sorgenfrei 2006</a>
</td>
<td style="text-align:center;width: 6em; ">
27
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:left;width: 10em; ">
Denmark
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1951
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1951">de Boer 2007</a>
</td>
<td style="text-align:center;width: 6em; ">
45
</td>
<td style="text-align:center;width: 6em; ">
4
</td>
<td style="text-align:left;width: 10em; ">
Netherlands
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2000
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2000">Sacan 2007</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2003
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2003">Sparr 2007</a>
</td>
<td style="text-align:center;width: 6em; ">
94
</td>
<td style="text-align:center;width: 6em; ">
3
</td>
<td style="text-align:left;width: 10em; ">
Netherlands
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2004
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2004">Suy 2007</a>
</td>
<td style="text-align:center;width: 6em; ">
39
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:left;width: 10em; ">
Belgium
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2005
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2005">Suzuki 2007</a>
</td>
<td style="text-align:center;width: 6em; ">
70
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
Gyn
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2040
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2040">Flockton 2008</a>
</td>
<td style="text-align:center;width: 6em; ">
73
</td>
<td style="text-align:center;width: 6em; ">
8
</td>
<td style="text-align:left;width: 10em; ">
UK
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2049
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2049">Jones 2008</a>
</td>
<td style="text-align:center;width: 6em; ">
75
</td>
<td style="text-align:center;width: 6em; ">
8
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2073
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2073">Puhringer 2008</a>
</td>
<td style="text-align:center;width: 6em; ">
173
</td>
<td style="text-align:center;width: 6em; ">
6
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2088
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2088">Staals 2008</a>
</td>
<td style="text-align:center;width: 6em; ">
29
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:left;width: 10em; ">
Netherlands
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2124
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2124">Dahl 2009</a>
</td>
<td style="text-align:center;width: 6em; ">
116
</td>
<td style="text-align:center;width: 6em; ">
11
</td>
<td style="text-align:left;width: 10em; ">
Norway
</td>
<td style="text-align:left;width: 12em; ">
Gen
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2209
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2209">Blobner 2010</a>
</td>
<td style="text-align:center;width: 6em; ">
96
</td>
<td style="text-align:center;width: 6em; ">
13
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2234
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2234">Fuchs-Buder 2010</a>
</td>
<td style="text-align:center;width: 6em; ">
120
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
France
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2251
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2251">Khuenl-Brady 2010</a>
</td>
<td style="text-align:center;width: 6em; ">
93
</td>
<td style="text-align:center;width: 6em; ">
13
</td>
<td style="text-align:left;width: 10em; ">
Austria
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2254
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2254">Lederer 2010</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Austria
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2260
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2260">Lemmens 2010</a>
</td>
<td style="text-align:center;width: 6em; ">
82
</td>
<td style="text-align:center;width: 6em; ">
8
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2281
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2281">Puhringer 2010</a>
</td>
<td style="text-align:center;width: 6em; ">
48
</td>
<td style="text-align:center;width: 6em; ">
6
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2287
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2287">Schaller 2010</a>
</td>
<td style="text-align:center;width: 6em; ">
94
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2308
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2308">Adamus 2011</a>
</td>
<td style="text-align:center;width: 6em; ">
21
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Czech Republic
</td>
<td style="text-align:left;width: 12em; ">
Neuro
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2335
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2335">Illman 2011</a>
</td>
<td style="text-align:center;width: 6em; ">
47
</td>
<td style="text-align:center;width: 6em; ">
4
</td>
<td style="text-align:left;width: 10em; ">
Finland
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2338
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2338">Jeong 2011</a>
</td>
<td style="text-align:center;width: 6em; ">
52
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2361
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2361">McDonagh 2011</a>
</td>
<td style="text-align:center;width: 6em; ">
150
</td>
<td style="text-align:center;width: 6em; ">
14
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2382
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2382">Sauer 2011</a>
</td>
<td style="text-align:center;width: 6em; ">
114
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Ortho
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
6002
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#6002">Sabo 2011</a>
</td>
<td style="text-align:center;width: 6em; ">
97
</td>
<td style="text-align:center;width: 6em; ">
5
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gi, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2438
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2438">Gaszynski 2012</a>
</td>
<td style="text-align:center;width: 6em; ">
70
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Poland
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2439
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2439">Geldner 2012</a>
</td>
<td style="text-align:center;width: 6em; ">
133
</td>
<td style="text-align:center;width: 6em; ">
10
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4788
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4788">Mekawy 2012</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Oralmax
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2502
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2502">Alkenany 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2514
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2514">Carron 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Italy
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2534
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2534">Fuchs-Buder 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
48
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
France
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2591
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2591">Pongracz 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
75
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Hungary
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2618
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2618">Woo 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
118
</td>
<td style="text-align:center;width: 6em; ">
7
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2632
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2632">Czarnetzki 2014</a>
</td>
<td style="text-align:center;width: 6em; ">
32
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Switzerland
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2673
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2673">Martini 2014</a>
</td>
<td style="text-align:center;width: 6em; ">
24
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:left;width: 10em; ">
Netherlands
</td>
<td style="text-align:left;width: 12em; ">
Gen, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2710
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2710">Wu 2014</a>
</td>
<td style="text-align:center;width: 6em; ">
291
</td>
<td style="text-align:center;width: 6em; ">
10
</td>
<td style="text-align:left;width: 10em; ">
China<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
7109
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#7109">Castro 2014</a>
</td>
<td style="text-align:center;width: 6em; ">
88
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Portugal
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2725
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2725">Brueckmann 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
150
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Gen, Abdominal
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2729
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2729">Cheong 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
120
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2738
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2738">Germano Filho 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
73
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Brazil<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2757
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2757">Karwacki 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
38
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Poland
</td>
<td style="text-align:left;width: 12em; ">
Neuro
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2764
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2764">Koyuncu 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
100
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Gen
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2793
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2793">Rahe-Meyer 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
134
</td>
<td style="text-align:center;width: 6em; ">
10
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2802
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2802">Song 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
48
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2806
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2806">Tassonyi 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
48
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Hungary
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2809
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2809">Unal 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
74
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2864
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2864">Hakimoglu 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Ortho
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2875
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2875">Kaufhold 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
98
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2880
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2880">Kim 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
80
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2917
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2917">Preault 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
France
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gi, Ortho, ENT, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2918
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2918">Putz 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
100
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Belgium
</td>
<td style="text-align:left;width: 12em; ">
Gyn
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2975
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2975">Alsaeed 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
110
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Saudi Arabia
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2979
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2979">Asztalos 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
65
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Hungary
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2995
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2995">Choi 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3058
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3058">Nemes 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
128
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Hungary
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3063
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3063">Loh 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
120
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Malaysia
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gen, Neuro, Opth, Ortho, Urol, Abdominal
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3089
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3089">Tas Tuna 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
80
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3098
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3098">Yagan 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
98
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Gen, ENT, Ortho, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4148
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4148">Evron 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
57
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Israel
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
7226
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#7226">El Sherbeny 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
100
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Cr, Gyn
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3104
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3104">Abdulatif 2018</a>
</td>
<td style="text-align:center;width: 6em; ">
55
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3190
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3190">Paech 2018</a>
</td>
<td style="text-align:center;width: 6em; ">
304
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Australia
</td>
<td style="text-align:left;width: 12em; ">
Gyn
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3233
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3233">Alday 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
126
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Spain
</td>
<td style="text-align:left;width: 12em; ">
Cr, Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3261
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3261">Claroni 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
109
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Italy
</td>
<td style="text-align:left;width: 12em; ">
Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3285
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3285">Gunes 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
129
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3302
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3302">Kim 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
84
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Opth
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3338
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3338">Quang 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
70
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Vietnam<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3353
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3353">Schepens 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
55
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Netherlands
</td>
<td style="text-align:left;width: 12em; ">
Neuro
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4003
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4003">Citil 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Thor
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3376
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3376">Abola 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
56
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gen, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3390
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3390">Boggett 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
350
</td>
<td style="text-align:center;width: 6em; ">
4
</td>
<td style="text-align:left;width: 10em; ">
Australia
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gen, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3410
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3410">Deana 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
41
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Italy
</td>
<td style="text-align:left;width: 12em; ">
Hep
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3468
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3468">Lee 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
73
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Gen
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3487
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3487">Moon 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
92
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Thor
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3492
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3492">Niu 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
102
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
China<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3540
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3540">Togioka 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
197
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Gen, Ortho, ENT, Plastic, Urol, Abdominal
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3553
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3553">Williams 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
100
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3566
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3566">Zhu 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
120
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
China<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4631
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4631">Kurcaloglu 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Neuro
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4943
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4943">Ornek 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
5414
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#5414">Van Dong 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
84
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Vietnam<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Gi, Gen, Hep
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3594
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3594">Farag 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
68
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Neuro
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3608
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3608">Han 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
75
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3612
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3612">Horrow 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
188
</td>
<td style="text-align:center;width: 6em; ">
20
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3621
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3621">Lee 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
93
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Thor
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3625
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3625">Li 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
118
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
China<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4663
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4663">Ledowski 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
168
</td>
<td style="text-align:center;width: 6em; ">
5
</td>
<td style="text-align:left;width: 10em; ">
Australia
</td>
<td style="text-align:left;width: 12em; ">
Gen, Ortho
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
7015
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#7015">Duranteau 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
56
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Belgium
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr grouplength="1">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
Quasi-Experimental
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
7078
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#7078">Suganuma 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
19
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
Gyn
</td>
</tr>
<tr grouplength="8">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
Nonrandomized Studies of Interventions
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3460
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3460">Krause 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
7316
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various, Car, Gyn, Gen, Neuro, Ortho, ENT, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2523
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2523">Della Rocca 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
357
</td>
<td style="text-align:center;width: 6em; ">
12
</td>
<td style="text-align:left;width: 10em; ">
Italy
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2600
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2600">Sanfilippo 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Italy
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2615
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2615">von Quillfeldt 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
39
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Germany
</td>
<td style="text-align:left;width: 12em; ">
Opth
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4997
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4997">Pecek 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
20
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Slovenia
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Ortho, ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2961
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2961">Yazar 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
59
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3178
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3178">Muramatsu 2018</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4465
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4465">Johnson 2018</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
UK
</td>
<td style="text-align:left;width: 12em; ">
Gi, Gen
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3491
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3491">Murphy 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
197
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Thor
</td>
</tr>
<tr grouplength="11">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
Prospective Cohort
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1166
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1166">Joshi 1999</a>
</td>
<td style="text-align:center;width: 6em; ">
100
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Gyn, ENT, Ortho, Plastic
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1921
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1921">Suzuki 2006</a>
</td>
<td style="text-align:center;width: 6em; ">
45
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
Gyn
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2304
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2304">Yip 2010</a>
</td>
<td style="text-align:center;width: 6em; ">
94
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
New Zealand
</td>
<td style="text-align:left;width: 12em; ">
Gen, Hep, Neuro, Ortho, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2419
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2419">Cammu 2012</a>
</td>
<td style="text-align:center;width: 6em; ">
624
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Belgium
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gi, Oralmax, Ortho, ENT, Plastic, Thor
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2550
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2550">Kadoi 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
17
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2557
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2557">Kotake 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
249
</td>
<td style="text-align:center;width: 6em; ">
5
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2560
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2560">Ledowski 2013</a>
</td>
<td style="text-align:center;width: 6em; ">
146
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Australia
</td>
<td style="text-align:left;width: 12em; ">
Gen, Ortho, Plastic
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2644
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2644">Fujita 2014</a>
</td>
<td style="text-align:center;width: 6em; ">
31
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
Hep
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2731
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2731">de Souza 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:left;width: 10em; ">
Brazil<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2831
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2831">Badaoui 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
64
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
France
</td>
<td style="text-align:left;width: 12em; ">
Gi
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2834
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2834">Batistaki 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
520
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Greece
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr grouplength="10">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
Retrospective Cohort
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2896
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2896">Martinez-Ubieto 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
555
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Spain
</td>
<td style="text-align:left;width: 12em; ">
Gen, Oralmax, ENT, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2197
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2197">White 2009</a>
</td>
<td style="text-align:center;width: 6em; ">
171
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3986
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3986">Cho 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
50
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Thor
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3176
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3176">Miyazaki 2018</a>
</td>
<td style="text-align:center;width: 6em; ">
15479
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3237
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3237">Arslantas 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
42
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3441
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3441">John 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
277
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3451
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3451">Kheterpal 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
45712
</td>
<td style="text-align:center;width: 6em; ">
12
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gi, ENT, Ortho, Thor, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3929
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3929">Burbridge 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
19821
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4560
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4560">Kim 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
15586
</td>
<td style="text-align:center;width: 6em; ">
5
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gen, ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3667
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3667">Yu 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
906
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
South Korea
</td>
<td style="text-align:left;width: 12em; ">
Urol
</td>
</tr>
<tr grouplength="5">
<td colspan="6" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>All ages</strong>
</td>
</tr>
<tr grouplength="4">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
RCT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4692
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4692">Li 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
10491
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Gen, Hep
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
732
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#732">Abdulatif 1996</a>
</td>
<td style="text-align:center;width: 6em; ">
90
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1132
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1132">Bevan 1999</a>
</td>
<td style="text-align:center;width: 6em; ">
176
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Canada
</td>
<td style="text-align:left;width: 12em; ">
Gyn
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
1198
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#1198">McCourt 1999</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:left;width: 10em; ">
UK
</td>
<td style="text-align:left;width: 12em; ">
Gen, Ortho, ENT
</td>
</tr>
<tr grouplength="1">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
Retrospective Cohort
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2177
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2177">Plaud 2009</a>
</td>
<td style="text-align:center;width: 6em; ">
91
</td>
<td style="text-align:center;width: 6em; ">
6
</td>
<td style="text-align:left;width: 10em; ">
France
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr grouplength="17">
<td colspan="6" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>Pediatric</strong>
</td>
</tr>
<tr grouplength="12">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
RCT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3495
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3495">Orihara 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
33119
</td>
<td style="text-align:center;width: 6em; ">
4
</td>
<td style="text-align:left;width: 10em; ">
Japan
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
124
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#124">Gwinnutt 1991</a>
</td>
<td style="text-align:center;width: 6em; ">
30
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
UK
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
631
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#631">Kirkegaard-Nielsen 1995</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Finland
</td>
<td style="text-align:left;width: 12em; ">
Gen, Ortho
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
724
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#724">Watcha 1995</a>
</td>
<td style="text-align:center;width: 6em; ">
75
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2681
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2681">Ozgun 2014</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
7030
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#7030">Kara 2014</a>
</td>
<td style="text-align:center;width: 6em; ">
80
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
Gen, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2741
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2741">Ghoneim 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
40
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Neuro
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4114
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4114">El sayed 2016</a>
</td>
<td style="text-align:center;width: 6em; ">
70
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2976
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2976">Ammar 2017</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Gi, Abdominal
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3306
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3306">Korkmaz 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
70
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Turkey
</td>
<td style="text-align:left;width: 12em; ">
ENT
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3556
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3556">Xiaobing 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
China<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Car
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
4399
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#4399">Hussein 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
80
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Egypt<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Oralmax
</td>
</tr>
<tr grouplength="4">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
Prospective Cohort
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3628
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3628">Li 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
60
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
China<sup>a</sup>
</td>
<td style="text-align:left;width: 12em; ">
Car
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
2767
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2767">Ledowski 2015</a>
</td>
<td style="text-align:center;width: 6em; ">
64
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Australia
</td>
<td style="text-align:left;width: 12em; ">
Gen, Ortho, ENT, Plastic, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3381
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3381">Alsuhebani 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
221
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Car, Gen, ENT, Ortho
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3384
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3384">Arends 2020</a>
</td>
<td style="text-align:center;width: 6em; ">
92
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Car, Gen
</td>
</tr>
<tr grouplength="1">
<td colspan="6" style="border-bottom: 0px solid;color: black !important;background-color: white !important;">
Case-control
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; padding-left: 2em;" indentlevel="1">
3574
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3574">Alenezi 2021</a>
</td>
<td style="text-align:center;width: 6em; ">
30
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
Saudi Arabia
</td>
<td style="text-align:left;width: 12em; ">
Gyn, Gen, ENT, Plastic, Urol
</td>
</tr>
<tr>
<td style="text-align:left;width: 6em; ">
3280
</td>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3280">Gaver 2019</a>
</td>
<td style="text-align:center;width: 6em; ">
1936
</td>
<td style="text-align:center;width: 6em; ">
1
</td>
<td style="text-align:left;width: 10em; ">
USA
</td>
<td style="text-align:left;width: 12em; ">
Various
</td>
</tr>
</tbody>
<tfoot>
<tr>
<td style="padding: 0; " colspan="100%">
<sup></sup> RCT: randomized controlled trial.
</td>
</tr>
<tr>
<td style="padding: 0; " colspan="100%">
<sup>a</sup> Non very high <a href="https://en.wikipedia.org/wiki/List_of_countries_by_Human_Development_Index">Human Development Index</a> country.
</td>
</tr>
</tfoot>
</table>
</div>
</div>
<div id="outcomes" class="section level1">
<h1><strong>Outcomes</strong></h1>
<p><br/></p>
<div id="residual-neuromusclar-block-tofrclinical" class="section level2">
<h2><em>Residual Neuromusclar Block (TOFR/Clinical)</em></h2>
<p><br/></p>
<div id="adult" class="section level3">
<h3>Adult</h3>
</div>
<div id="agents-anesthetics-and-monitors" class="section level3">
<h3> Agents, Anesthetics, and Monitors</h3>
<p><br/></p>
<p><font size = 4> Table 3. Reversal and neuromuscular blocking agents, anesthetic, and monitor in studies reporting residual neuromuscular block in adults. </font></p>
<table class="table table-striped table-hover table-condensed lightable-classic lightable-hover" style="width: auto !important;  font-family: Source Sans Pro; width: auto !important; border-bottom: 0;">
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="2">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; font-weight: bold; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Reversal
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; font-weight: bold; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
NMBA
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; font-weight: bold; " colspan="3">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Anesthetic
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; font-weight: bold; " colspan="4">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Monitor
</div>
</th>
</tr>
<tr>
<th style="text-align:left;font-weight: bold;">
Study
</th>
<th style="text-align:left;font-weight: bold;">
N
</th>
<th style="text-align:center;font-weight: bold;">
Agent
</th>
<th style="text-align:center;font-weight: bold;">
mg/kg (mg)
</th>
<th style="text-align:center;font-weight: bold;">
Roc
</th>
<th style="text-align:center;font-weight: bold;">
Vec
</th>
<th style="text-align:center;font-weight: bold;">
TIVA
</th>
<th style="text-align:center;font-weight: bold;">
Inh
</th>
<th style="text-align:center;font-weight: bold;">
NS
</th>
<th style="text-align:center;font-weight: bold;">
AMG
</th>
<th style="text-align:center;font-weight: bold;">
EMG
</th>
<th style="text-align:left;font-weight: bold;">
KMG
</th>
<th style="text-align:left;font-weight: bold;">
NS
</th>
</tr>
</thead>
<tbody>
<tr grouplength="30">
<td colspan="13" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>RCT</strong>
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2260">Lemmens 2010</a>
</td>
<td style="text-align:left;width: 4em; ">
47
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.07
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
47
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2251">Khuenl-Brady 2010</a>
</td>
<td style="text-align:left;width: 4em; ">
45
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.05
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
48
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#6002">Sabo 2011</a>
</td>
<td style="text-align:left;width: 4em; ">
49
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.05
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
51
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
4
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2308">Adamus 2011</a>
</td>
<td style="text-align:left;width: 4em; ">
10
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.04
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
11
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2710">Wu 2014 (Chinese)</a>
</td>
<td style="text-align:left;width: 4em; ">
111
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.05
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
120
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2710">Wu 2014 (Caucasian)</a>
</td>
<td style="text-align:left;width: 4em; ">
31
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.05
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
29
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2729">Cheong 2015</a>
</td>
<td style="text-align:left;width: 4em; ">
30
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.05
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
30
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2725">Brueckmann 2015</a>
</td>
<td style="text-align:left;width: 4em; ">
77
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.02-0.08
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
74
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2-4
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#7226">El Sherbeny 2017</a>
</td>
<td style="text-align:left;width: 4em; ">
20
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.05
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
20
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
3
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3058">Nemes 2017</a>
</td>
<td style="text-align:left;width: 4em; ">
22
</td>
<td style="text-align:center;width: 4em; ">
Placebo
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
50
</td>
<td style="text-align:center;width: 4em; ">
Spont
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
26
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.05
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
27
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3233">Alday 2019</a>
</td>
<td style="text-align:left;width: 4em; ">
64
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.04
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
62
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3390">Boggett 2020</a>
</td>
<td style="text-align:left;width: 4em; ">
175
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
<ol start="5" style="list-style-type: decimal">
<li></td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
×
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
175
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2-4
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
×
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3468">Lee 2020</a>
</td>
<td style="text-align:left;width: 4em; ">
36
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.02-0.05
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
37
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2-4
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3540">Togioka 2020</a>
</td>
<td style="text-align:left;width: 4em; ">
99
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.07
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
98
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr grouplength="8">
<td colspan="13" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>Prospective Cohort</strong>
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2419">Cammu 2012</a>
</td>
<td style="text-align:left;width: 4em; ">
139
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.08
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
44
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
1-4
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2557">Kotake 2013</a>
</td>
<td style="text-align:left;width: 4em; ">
23
</td>
<td style="text-align:center;width: 4em; ">
Spont
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
109
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.03
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
117
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2-4
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2560">Ledowski 2013</a>
</td>
<td style="text-align:left;width: 4em; ">
53
</td>
<td style="text-align:center;width: 4em; ">
Spont
</td>
<td style="text-align:center;width: 6em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
33
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
(1.25-50)
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
57
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
<ol start="200" style="list-style-type: decimal">
<li></td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
</tr>
<tr grouplength="2">
<td colspan="13" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>Retrospective Cohort</strong>
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3441">John 2020</a>
</td>
<td style="text-align:left;width: 4em; ">
143
</td>
<td style="text-align:center;width: 4em; ">
Neo
</td>
<td style="text-align:center;width: 6em; ">
0.04
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
×
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 4em; ">
134
</td>
<td style="text-align:center;width: 4em; ">
Sug
</td>
<td style="text-align:center;width: 6em; ">
2
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
×
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:center;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
</td>
<td style="text-align:left;width: 4em; ">
×
</td>
</tr>
</tbody>
<tfoot>
<tr>
<td style="padding: 0; " colspan="100%">
<sup></sup> NMBA: neuromuscular blocking agent; Neo: neostigmine; Sug: sugammadex; Spont: spontaneous; Roc: rocuronium; Vec: vecuronium; TIVA: total intravenous anesthesia; Inh: inhalation; NS: not specified; AMG: acceleromyography; EMG: electromyography; KMG: kinemyography; nl: normalized AMG.
</td>
</tr>
</tfoot>
</table></li>
</ol></li>
</ol>
<p><br/></p>
<p><br/></p>
</div>
<div id="incidence" class="section level3">
<h3> Incidence</h3>
<p><br/></p>
<p><font size = 4> Table 4. Incidence of residual neuromuscular block by TOFR and depth of anesthesia according to reversal in adults.</font> (<b><font color = "#7173a7">spontaneous</font>, <font color = "#cfa975">placebo</font>, <font color = "#b8bb6b">neostigimine</font>, or <font color = "#03b016">sugammadex</font></b>),</font></p>
<table class="table table-striped table-hover table-condensed lightable-classic lightable-hover" style="width: auto !important;  font-family: Source Sans Pro; width: auto !important; border-bottom: 0;">
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="2">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; font-weight: bold; " colspan="1">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Reversal
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; font-weight: bold; " colspan="5">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Depth of Block<sup>a</sup>
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; font-weight: bold; " colspan="5">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Residual Neuromuscular Block
</div>
</th>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1">
</th>
</tr>
<tr>
<th style="text-align:left;font-weight: bold;">
Study
</th>
<th style="text-align:left;font-weight: bold;">
N
</th>
<th style="text-align:center;font-weight: bold;">
Agent
</th>
<th style="text-align:center;font-weight: bold;">
Deep
</th>
<th style="text-align:center;font-weight: bold;">
Mod
</th>
<th style="text-align:center;font-weight: bold;">
Shal
</th>
<th style="text-align:center;font-weight: bold;">
Min
</th>
<th style="text-align:left;font-weight: bold;">
NS
</th>
<th style="text-align:left;font-weight: bold;">
&lt;1.0
</th>
<th style="text-align:left;font-weight: bold;">
&lt;0.9
</th>
<th style="text-align:left;font-weight: bold;">
&lt;0.7
</th>
<th style="text-align:left;font-weight: bold;">
Clin
</th>
<th style="text-align:left;font-weight: bold;">
NS
</th>
<th style="text-align:left;font-weight: bold;">
OR (95% CI)<sup>b</sup>
</th>
</tr>
</thead>
<tbody>
<tr grouplength="30">
<td colspan="14" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>RCT</strong>
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2260">Lemmens 2010</a>
</td>
<td style="text-align:left;width: 2em; ">
47
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
47
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2251">Khuenl-Brady 2010</a>
</td>
<td style="text-align:left;width: 2em; ">
45
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  82.22% , #b8bb6b 82.22% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">8 (18)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.05 (0.00-0.81)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
48
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#6002">Sabo 2011</a>
</td>
<td style="text-align:left;width: 2em; ">
49
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  46.94% , #b8bb6b 46.94% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">26 (53)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  69.39% , #b8bb6b 69.39% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">15 (31)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.04 (0.01-0.17)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
51
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  96.08% , #03b016 96.08% , #03b016 100.00% , transparent 100.00% ); width: 100%">2 (4)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  98.04% , #03b016 98.04% , #03b016 100.00% , transparent 100.00% ); width: 100%">1 (2)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2308">Adamus 2011</a>
</td>
<td style="text-align:left;width: 2em; ">
10
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
11
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2710">Wu 2014 (Chinese)</a>
</td>
<td style="text-align:left;width: 2em; ">
111
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
120
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2710">Wu 2014 (Caucasian)</a>
</td>
<td style="text-align:left;width: 2em; ">
31
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
29
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2729">Cheong 2015</a>
</td>
<td style="text-align:left;width: 2em; ">
30
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
30
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2725">Brueckmann 2015</a>
</td>
<td style="text-align:left;width: 2em; ">
77
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  57.14% , #b8bb6b 57.14% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">33 (43)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  89.61% , #b8bb6b 89.61% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">8 (10)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.01 (0.00-0.15)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
74
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#7226">El Sherbeny 2017</a>
</td>
<td style="text-align:left;width: 2em; ">
20
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #b8bb6b 100.00% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
20
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3058">Nemes 2017</a>
</td>
<td style="text-align:left;width: 2em; ">
22
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #cfa975 !important;">Placebo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #cfa975  NA , #cfa975 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  54.55% , #cfa975 54.55% , #cfa975 100.00% , transparent 100.00% ); width: 100%">10 (45)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #cfa975  NA , #cfa975 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #cfa975  NA , #cfa975 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.05 (0.01-0.40)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
50
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #9597e9 !important;">Spont</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #9597e9  NA , #9597e9 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  74.00% , #9597e9 74.00% , #9597e9 100.00% , transparent 100.00% ); width: 100%">13 (26)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #9597e9  NA , #9597e9 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #9597e9  NA , #9597e9 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.11 (0.01-0.89)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
26
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  84.62% , #b8bb6b 84.62% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">4 (15)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.21 (0.02-2.03)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
27
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  96.30% , #03b016 96.30% , #03b016 100.00% , transparent 100.00% ); width: 100%">1 (4)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3233">Alday 2019</a>
</td>
<td style="text-align:left;width: 2em; ">
64
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  29.69% , #b8bb6b 29.69% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">45 (70)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  82.81% , #b8bb6b 82.81% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">11 (17)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.19 (0.09-0.40)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
62
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  69.35% , #03b016 69.35% , #03b016 100.00% , transparent 100.00% ); width: 100%">19 (31)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  93.55% , #03b016 93.55% , #03b016 100.00% , transparent 100.00% ); width: 100%">4 (6)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3390">Boggett 2020</a>
</td>
<td style="text-align:left;width: 2em; ">
175
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  96.57% , #b8bb6b 96.57% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">6 (3)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
175
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  97.14% , #03b016 97.14% , #03b016 100.00% , transparent 100.00% ); width: 100%">5 (3)</span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3468">Lee 2020</a>
</td>
<td style="text-align:left;width: 2em; ">
36
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  55.56% , #b8bb6b 55.56% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">16 (44)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.02 (0.00-0.29)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
37
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3540">Togioka 2020</a>
</td>
<td style="text-align:left;width: 2em; ">
99
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  53.54% , #b8bb6b 53.54% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">46 (46)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  78.79% , #b8bb6b 78.79% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">21 (21)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.12 (0.05-0.26)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
98
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
×
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  90.82% , #03b016 90.82% , #03b016 100.00% , transparent 100.00% ); width: 100%">9 (9)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  96.94% , #03b016 96.94% , #03b016 100.00% , transparent 100.00% ); width: 100%">3 (3)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr grouplength="8">
<td colspan="14" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>Prospective Cohort</strong>
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2419">Cammu 2012</a>
</td>
<td style="text-align:left;width: 2em; ">
139
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  84.89% , #b8bb6b 84.89% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">21 (15)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.13 (0.02-1.00)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
44
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  97.73% , #03b016 97.73% , #03b016 100.00% , transparent 100.00% ); width: 100%">1 (2)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2557">Kotake 2013</a>
</td>
<td style="text-align:left;width: 2em; ">
23
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #9597e9 !important;">Spont</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  30.43% , #9597e9 30.43% , #9597e9 100.00% , transparent 100.00% ); width: 100%">16 (70)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  86.96% , #9597e9 86.96% , #9597e9 100.00% , transparent 100.00% ); width: 100%">3 (13)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #9597e9  NA , #9597e9 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #9597e9  NA , #9597e9 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.30 (0.07-1.35)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
109
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  33.03% , #b8bb6b 33.03% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">73 (67)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  76.15% , #b8bb6b 76.15% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">26 (24)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.14 (0.05-0.39)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
117
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  53.85% , #03b016 53.85% , #03b016 100.00% , transparent 100.00% ); width: 100%">54 (46)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  95.73% , #03b016 95.73% , #03b016 100.00% , transparent 100.00% ); width: 100%">5 (4)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#2560">Ledowski 2013</a>
</td>
<td style="text-align:left;width: 2em; ">
53
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #9597e9 !important;">Spont</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #9597e9  NA , #9597e9 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  54.72% , #9597e9 54.72% , #9597e9 100.00% , transparent 100.00% ); width: 100%">24 (45)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  84.91% , #9597e9 84.91% , #9597e9 100.00% , transparent 100.00% ); width: 100%">8 (15)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #9597e9  NA , #9597e9 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.09 (0.03-0.29)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
33
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  42.42% , #b8bb6b 42.42% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">19 (58)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  72.73% , #b8bb6b 72.73% , #b8bb6b 100.00% , transparent 100.00% ); width: 100%">9 (27)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
0.06 (0.02-0.19)
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
57
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  92.98% , #03b016 92.98% , #03b016 100.00% , transparent 100.00% ); width: 100%">4 (7)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent  100.00% , #03b016 100.00% , #03b016 100.00% , transparent 100.00% ); width: 100%">0 (0)</span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr grouplength="2">
<td colspan="14" style="border-top: 1px solid;color: black !important;background-color: #EBEBEB !important;">
<strong>Retrospective Cohort</strong>
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
<a href="evidence_tables.html#3441">John 2020</a>
</td>
<td style="text-align:left;width: 2em; ">
143
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #466649 !important;">Neo</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #b8bb6b  NA , #b8bb6b 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
0 (0)
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
<tr>
<td style="text-align:left;width: 10em; ">
</td>
<td style="text-align:left;width: 2em; ">
134
</td>
<td style="text-align:center;width: 4em; ">
<span style="     color: #03b016 !important;">Sug</span>
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:center;width: 3em; ">
</td>
<td style="text-align:left;width: 3em; ">
×
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 4em; ">
<span style="display: inline-block; unicode-bidi: plaintext; background: linear-gradient(270deg, transparent   NA , #03b016  NA , #03b016 100.00% , transparent 100.00% ); width: 100%"></span>
</td>
<td style="text-align:left;width: 3em; ">
0 (0)
</td>
<td style="text-align:left;width: 8em; ">
</td>
</tr>
</tbody>
<tfoot>
<tr>
<td style="padding: 0; " colspan="100%">
<sup></sup> OR: odds ratio; Neo: neostigmine; Sug: sugammadex; Spont: spontaneous; Roc: rocuronium; Vec: vecuronium; NS: not specified; nl: normalized AMG.
</td>
</tr>
<tr>
<td style="padding: 0; " colspan="100%">
<sup>a</sup> Depth of block.
</td>
</tr>
<tr>
<td style="padding: 0; " colspan="100%">
<sup>b</sup> Comparing the 2nd or last arm with previous. If no events in one arm, continuity correction used to estimate OR.
</td>
</tr>
</tfoot>
</table>
<p><br/></p>
<p><a id="revFig1"></a></p>
</div>
<div id="pooled-adult-rcts" class="section level3">
<h3> Pooled (adult RCTs)</h3>
<p><br/></p>
<p><font size = 4> Figure 1. Pooled residual neuromuscular block (TOFR &lt;0.9) from randomized trials comparing sugammadex and neostigmine. </font></p>
<p><img src="figure/reversal.Rmd/rnmbMetaRct-1.png" width="960" style="display: block; margin: auto auto auto 0;" /></p>
<p>
<button type="button" class="btn btn-default btn-xs btn-workflowr btn-workflowr-fig" data-toggle="collapse" data-target="#fig-rnmbMetaRct-1">
Past versions of rnmbMetaRct-1.png
</button>
</p>
<div id="fig-rnmbMetaRct-1" class="collapse">
<div class="table-responsive">
<table class="table table-condensed table-hover">
<thead>
<tr>
<th>
Version
</th>
<th>
Author
</th>
<th>
Date
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<a href="https://github.com/mdgrant/NMB/blob/ee9df67744de661cde5e21dc0714ec1cac38792e/docs/figure/reversal.Rmd/rnmbMetaRct-1.png" target="_blank">ee9df67</a>
</td>
<td>
Mark Grant
</td>
<td>
2022-01-12
</td>
</tr>
<tr>
<td>
<a href="https://github.com/mdgrant/NMB/blob/bbf041610ac4cb7a192fd55f53b26d6af2df550d/docs/figure/reversal.Rmd/rnmbMetaRct-1.png" target="_blank">bbf0416</a>
</td>
<td>
Mark Grant
</td>
<td>
2022-01-12
</td>
</tr>
</tbody>
</table>
</div>
</div>
</div>
</div>
</div>
<div id="risk-of-bias" class="section level1">
<h1><strong>Risk of Bias</strong></h1>
<p><br/></p>
<div id="rcts-clinical-outcomes" class="section level3">
<h3><em>RCTs Clinical Outcomes</em></h3>
<p><br></p>
<p><font size = 4> Figure 2. Summary risk of bias appraisal for included RCTs reporting RNMB. </font></p>
<p><img src="assets/reversal_rnmb_rob_clin_out.svg" style="width:750px;" align="left"/></p>
<p><br clear="all" /></p>
<p><br/></p>
<p><font size = 4> Figure 3. Individual study risk of bias appraisal for reporting RNMB. </font></p>
<p><img src="assets/reversal_rnmb_clin_out_traffic.svg" style="width:650px;" align="left"/></p>
<p><br clear="all" /></p>
<hr style="height:2px;border-width:0;color:gray;background-color:gray">
<p><br></p>
</div>
</div>
<div id="references" class="section level1">
<h1>References</h1>
<p><a id="references"></a></p>
<div id="refs" class="references csl-bib-body">
<div id="ref-Cashman1990" class="csl-entry">
<div class="csl-left-margin">1. </div><div class="csl-right-inline">Cashman JN, Luke JJ, Jones RM. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function. <em>Br J Anaesth</em>. 1990;64(2):186-192. doi:<a href="https://doi.org/10.1093/bja/64.2.186">10.1093/bja/64.2.186</a></div>
</div>
<div id="ref-Magorian1990" class="csl-entry">
<div class="csl-left-margin">2. </div><div class="csl-right-inline">Magorian TT, Lynam DP, Caldwell JE, Miller RD. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? <em>Anesthesiology</em>. 1990;73(3):410-414. doi:<a href="https://doi.org/10.1097/00000542-199009000-00008">10.1097/00000542-199009000-00008</a></div>
</div>
<div id="ref-Abdulatif1991" class="csl-entry">
<div class="csl-left-margin">3. </div><div class="csl-right-inline">Abdulatif M, Naguib M. Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade. <em>Can J Anaesth</em>. 1991;38(2):159-163. doi:<a href="https://doi.org/10.1007/bf03008137">10.1007/bf03008137</a></div>
</div>
<div id="ref-Goldhill1991" class="csl-entry">
<div class="csl-left-margin">4. </div><div class="csl-right-inline">Goldhill DR, Carter JA, Suresh D, Whitehead JP, Flynn PJ. Antagonism of atracurium with neostigmine. Effect of dose on speed of recovery. <em>Anaesthesia</em>. 1991;46(6):496-499. doi:<a href="https://doi.org/10.1111/j.1365-2044.1991.tb11696.x">10.1111/j.1365-2044.1991.tb11696.x</a></div>
</div>
<div id="ref-Gwinnutt1991" class="csl-entry">
<div class="csl-left-margin">5. </div><div class="csl-right-inline">Gwinnutt CL, Walker RW, Meakin G. Antagonism of intense atracurium-induced neuromuscular block in children. <em>Br J Anaesth</em>. 1991;67(1):13-16. doi:<a href="https://doi.org/10.1093/bja/67.1.13">10.1093/bja/67.1.13</a></div>
</div>
<div id="ref-Phillips1992" class="csl-entry">
<div class="csl-left-margin">6. </div><div class="csl-right-inline">Phillips BJ, Hunter JM. Use of mivacurium chloride by constant infusion in the anephric patient. <em>Br J Anaesth</em>. 1992;68(5):492-498. doi:<a href="https://doi.org/10.1093/bja/68.5.492">10.1093/bja/68.5.492</a></div>
</div>
<div id="ref-Huang1993" class="csl-entry">
<div class="csl-left-margin">7. </div><div class="csl-right-inline">Huang CH, Wang MJ, Susetio L, et al. Comparison of the combined effects of atropine and neostigmine with atropine and edrophonium on the occurrence of postoperative nausea and vomiting. <em>Ma Zui Xue Za Zhi</em>. 1993;31(2):113-116.</div>
</div>
<div id="ref-Shorten1993" class="csl-entry">
<div class="csl-left-margin">8. </div><div class="csl-right-inline">Shorten GD, Ali HH, Goudsouzian NG. Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine. <em>Br J Anaesth</em>. 1993;70(2):160-162. doi:<a href="https://doi.org/10.1093/bja/70.2.160">10.1093/bja/70.2.160</a></div>
</div>
<div id="ref-Baurain1994" class="csl-entry">
<div class="csl-left-margin">9. </div><div class="csl-right-inline">Baurain MJ, Dernovoi BS, ’Hollander AA, Hennart DA. Comparison of neostigmine-induced recovery with spontaneous recovery from mivacurium-induced neuromuscular block. <em>Br J Anaesth</em>. 1994;73(6):791-794. doi:<a href="https://doi.org/10.1093/bja/73.6.791">10.1093/bja/73.6.791</a></div>
</div>
<div id="ref-Boeke1994" class="csl-entry">
<div class="csl-left-margin">10. </div><div class="csl-right-inline">Boeke AJ, Lange JJ e, Druenen B van, Langemeijer JJ. Effect of antagonizing residual neuromuscular block by neostigmine and atropine on postoperative vomiting. <em>Br J Anaesth</em>. 1994;72(6):654-656. doi:<a href="https://doi.org/10.1093/bja/72.6.654">10.1093/bja/72.6.654</a></div>
</div>
<div id="ref-Maddineni1994" class="csl-entry">
<div class="csl-left-margin">11. </div><div class="csl-right-inline">Maddineni VR, Mirakhur RK, McCoy EP. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion. <em>Anaesthesia</em>. 1994;49(11):946-948. doi:<a href="https://doi.org/10.1111/j.1365-2044.1994.tb04309.x">10.1111/j.1365-2044.1994.tb04309.x</a></div>
</div>
<div id="ref-McCoy1994" class="csl-entry">
<div class="csl-left-margin">12. </div><div class="csl-right-inline">McCoy EP, Mirakhur RK, Maddineni VR, Loan PB, Connolly F. Administration of rocuronium (org 9426) by continuous infusion and its reversibility with anticholinesterases. <em>Anaesthesia</em>. 1994;49(11):940-945. doi:<a href="https://doi.org/10.1111/j.1365-2044.1994.tb04308.x">10.1111/j.1365-2044.1994.tb04308.x</a></div>
</div>
<div id="ref-Motsch1994" class="csl-entry">
<div class="csl-left-margin">13. </div><div class="csl-right-inline">Motsch J, Leuwer M, Pfau M, Zimmerman J, Martin E. Time course of action and recovery of rocuronium bromide in children during halothane anaesthesia–a preliminary report. <em>Eur J Anaesthesiol Suppl</em>. 1994;9:75-77.</div>
</div>
<div id="ref-Puura1994" class="csl-entry">
<div class="csl-left-margin">14. </div><div class="csl-right-inline">Puura AI, Baer GA, Rorarius MG. Edrophonium is better than neostigmine to antagonize residual vecuronium induced neuromuscular block. <em>Acta Anaesthesiol Belg</em>. 1994;45(4):161-166.</div>
</div>
<div id="ref-Abdulatif1995" class="csl-entry">
<div class="csl-left-margin">15. </div><div class="csl-right-inline">Abdulatif M. Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block. <em>Br J Anaesth</em>. 1995;74(1):20-25. doi:<a href="https://doi.org/10.1093/bja/74.1.20">10.1093/bja/74.1.20</a></div>
</div>
<div id="ref-Connolly1995" class="csl-entry">
<div class="csl-left-margin">16. </div><div class="csl-right-inline">Connolly FM, Mirakhur RK, Loan PB, McCoy EP, Symington M, Kumar N. Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery. <em>Br J Anaesth</em>. 1995;74(2):229-230. doi:<a href="https://doi.org/10.1093/bja/74.2.229">10.1093/bja/74.2.229</a></div>
</div>
<div id="ref-Davis1995" class="csl-entry">
<div class="csl-left-margin">17. </div><div class="csl-right-inline">Davis L, Jayarajah MJ, Toner CC, Flynn PJ. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: A preliminary report. <em>Eur J Anaesthesiol Suppl</em>. 1995;11:65-68.</div>
</div>
<div id="ref-Devcic1995" class="csl-entry">
<div class="csl-left-margin">18. </div><div class="csl-right-inline">Devcic A, Munshi CA, Gandhi SK, Kampine JP. Antagonism of mivacurium neuromuscular block: Neostigmine versus edrophonium. <em>Anesth Analg</em>. 1995;81(5):1005-1009. doi:<a href="https://doi.org/10.1097/00000539-199511000-00019">10.1097/00000539-199511000-00019</a></div>
</div>
<div id="ref-Gyermek1995" class="csl-entry">
<div class="csl-left-margin">19. </div><div class="csl-right-inline">Gyermek L, Cantley EM, Lee C. Antagonism of pancuronium- and pipecuronium-induced neuromuscular block. <em>Br J Anaesth</em>. 1995;74(4):410-414. doi:<a href="https://doi.org/10.1093/bja/74.4.410">10.1093/bja/74.4.410</a></div>
</div>
<div id="ref-Kirkegaard-Nielsen1995" class="csl-entry">
<div class="csl-left-margin">20. </div><div class="csl-right-inline">Kirkegaard-Nielsen H, Meretoja OA, Wirtavuori K. Reversal of atracurium-induced neuromuscular block in paediatric patients. <em>Acta Anaesthesiol Scand</em>. 1995;39(7):906-911. doi:<a href="https://doi.org/10.1111/j.1399-6576.1995.tb04196.x">10.1111/j.1399-6576.1995.tb04196.x</a></div>
</div>
<div id="ref-Marcotte1995" class="csl-entry">
<div class="csl-left-margin">21. </div><div class="csl-right-inline">Marcotte J, Drolet P, Perreault L, Girard M. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia. <em>Can J Anaesth</em>. 1995;42(10):879-883. doi:<a href="https://doi.org/10.1007/bf03011035">10.1007/bf03011035</a></div>
</div>
<div id="ref-Miller1995" class="csl-entry">
<div class="csl-left-margin">22. </div><div class="csl-right-inline">Miller DR, Bryson G, Martineau RJ, et al. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium. <em>Can J Anaesth</em>. 1995;42(11):996-1002. doi:<a href="https://doi.org/10.1007/bf03011072">10.1007/bf03011072</a></div>
</div>
<div id="ref-Motsch1995" class="csl-entry">
<div class="csl-left-margin">23. </div><div class="csl-right-inline">Motsch J, Leuwer M, Böttiger BW, Bach A, Schönstedt R, Martin E. Dose-response, time-course of action and recovery of rocuronium bromide in children during halothane anaesthesia. <em>Eur J Anaesthesiol Suppl</em>. 1995;11:73-78.</div>
</div>
<div id="ref-Trevien1995" class="csl-entry">
<div class="csl-left-margin">24. </div><div class="csl-right-inline">Trévien V, Lienhart A, Just B, Chandon M, Baras E, Camatte S. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade. <em>Acta Anaesthesiol Scand Suppl</em>. 1995;106:66-69. doi:<a href="https://doi.org/10.1111/j.1399-6576.1995.tb04314.x">10.1111/j.1399-6576.1995.tb04314.x</a></div>
</div>
<div id="ref-Watcha1995" class="csl-entry">
<div class="csl-left-margin">25. </div><div class="csl-right-inline">Watcha MF, Safavi FZ, McCulloch DA, Tan TS, White PF. Effect of antagonism of mivacurium-induced neuromuscular block on postoperative emesis in children. <em>Anesth Analg</em>. 1995;80(4):713-717. doi:<a href="https://doi.org/10.1097/00000539-199504000-00011">10.1097/00000539-199504000-00011</a></div>
</div>
<div id="ref-Abdulatif1996" class="csl-entry">
<div class="csl-left-margin">26. </div><div class="csl-right-inline">Abdulatif M, Mowafi H, l-Ghamdi A, el-Sanabary M. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults. <em>Br J Anaesth</em>. 1996;77(6):710-715. doi:<a href="https://doi.org/10.1093/bja/77.6.710">10.1093/bja/77.6.710</a></div>
</div>
<div id="ref-Baurain1996" class="csl-entry">
<div class="csl-left-margin">27. </div><div class="csl-right-inline">Baurain MJ, Hoton F, Dernovoi BS, ’Hollander AA. Influence and relative sensitivities of 50-hz and 100-hz tetanic stimuli on subsequent tetanic fade ratios in patients receiving vecuronium. <em>Anesth Analg</em>. 1996;82(1):139-142. doi:<a href="https://doi.org/10.1097/00000539-199601000-00025">10.1097/00000539-199601000-00025</a></div>
</div>
<div id="ref-Jan1996" class="csl-entry">
<div class="csl-left-margin">28. </div><div class="csl-right-inline">Jan GS, Tong WN, Chan AM, Hui TW, Lo JW. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients. <em>Anaesth Intensive Care</em>. 1996;24(5):585-589. doi:<a href="https://doi.org/10.1177/0310057x9602400514">10.1177/0310057x9602400514</a></div>
</div>
<div id="ref-Kao1996" class="csl-entry">
<div class="csl-left-margin">29. </div><div class="csl-right-inline">Kao YJ, Le ND. The reversal of profound mivacurium-induced neuromuscular blockade. <em>Can J Anaesth</em>. 1996;43(11):1128-1133. doi:<a href="https://doi.org/10.1007/bf03011839">10.1007/bf03011839</a></div>
</div>
<div id="ref-Kirkegaard-Nielsen1996" class="csl-entry">
<div class="csl-left-margin">30. </div><div class="csl-right-inline">Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS, Jensen EW. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade. <em>Can J Anaesth</em>. 1996;43(9):932-938. doi:<a href="https://doi.org/10.1007/bf03011807">10.1007/bf03011807</a></div>
</div>
<div id="ref-Meretoja1996" class="csl-entry">
<div class="csl-left-margin">31. </div><div class="csl-right-inline">Meretoja OA, Taivainen T, Wirtavuori K. Cisatracurium during halothane and balanced anaesthesia in children. <em>Paediatr Anaesth</em>. 1996;6(5):373-378. doi:<a href="https://doi.org/10.1046/j.1460-9592.1996.d01-8.x">10.1046/j.1460-9592.1996.d01-8.x</a></div>
</div>
<div id="ref-Naguib1996" class="csl-entry">
<div class="csl-left-margin">32. </div><div class="csl-right-inline">Naguib M, Selim M, Bakhamees HS, Samarkandi AH, Turkistani A. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade. <em>Anesthesiology</em>. 1996;84(5):1051-1059. doi:<a href="https://doi.org/10.1097/00000542-199605000-00006">10.1097/00000542-199605000-00006</a></div>
</div>
<div id="ref-Servin1996" class="csl-entry">
<div class="csl-left-margin">33. </div><div class="csl-right-inline">Servin FS, Lavaut E, Kleef U, Desmonts JM. Repeated doses of rocuronium bromide administered to cirrhotic and control patients receiving isoflurane. A clinical and pharmacokinetic study. <em>Anesthesiology</em>. 1996;84(5):1092-1100. doi:<a href="https://doi.org/10.1097/00000542-199605000-00011">10.1097/00000542-199605000-00011</a></div>
</div>
<div id="ref-Hovorka1997" class="csl-entry">
<div class="csl-left-margin">34. </div><div class="csl-right-inline">Hovorka J, Korttila K, Nelskylä K, et al. Reversal of neuromuscular blockade with neostigmine has no effect on the incidence or severity of postoperative nausea and vomiting. <em>Anesth Analg</em>. 1997;85(6):1359-1361. doi:<a href="https://doi.org/10.1097/00000539-199712000-00032">10.1097/00000539-199712000-00032</a></div>
</div>
<div id="ref-Jahr1997" class="csl-entry">
<div class="csl-left-margin">35. </div><div class="csl-right-inline">Jahr JS, Keller T, Williams MD, et al. To reverse or not to reverse: An evaluation of reversal of mivacurium chloride in women undergoing outpatient gynecological procedures. <em>Am J Ther</em>. 1997;4(9-10):315-322.</div>
</div>
<div id="ref-Lessard1997" class="csl-entry">
<div class="csl-left-margin">36. </div><div class="csl-right-inline">Lessard MR, Trépanier CA, Rouillard JF. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium. <em>Can J Anaesth</em>. 1997;44(8):836-842. doi:<a href="https://doi.org/10.1007/bf03013160">10.1007/bf03013160</a></div>
</div>
<div id="ref-Carroll1998" class="csl-entry">
<div class="csl-left-margin">37. </div><div class="csl-right-inline">Carroll MT, Mirakhur RK, Lowry D, Glover P, Kerr CJ. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium. <em>Anaesthesia</em>. 1998;53(8):744-748. doi:<a href="https://doi.org/10.1046/j.1365-2044.1998.00530.x">10.1046/j.1365-2044.1998.00530.x</a></div>
</div>
<div id="ref-Nelskyla1998" class="csl-entry">
<div class="csl-left-margin">38. </div><div class="csl-right-inline">Nelskylä K, Yli-Hankala A, Soikkeli A, Korttila K. Neostigmine with glycopyrrolate does not increase the incidence or severity of postoperative nausea and vomiting in outpatients undergoing gynaecological laparoscopy. <em>Br J Anaesth</em>. 1998;81(5):757-760. doi:<a href="https://doi.org/10.1093/bja/81.5.757">10.1093/bja/81.5.757</a></div>
</div>
<div id="ref-Bevan1999" class="csl-entry">
<div class="csl-left-margin">39. </div><div class="csl-right-inline">Bevan JC, Collins L, Fowler C, et al. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. <em>Anesth Analg</em>. 1999;89(2):333-339. doi:<a href="https://doi.org/10.1097/00000539-199908000-00016">10.1097/00000539-199908000-00016</a></div>
</div>
<div id="ref-Fuchs-Buder1999" class="csl-entry">
<div class="csl-left-margin">40. </div><div class="csl-right-inline">Fuchs-Buder T, Ziegenfuss T, Lysakowski K, Tassonyi E. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: Dose-effect relationship of neostigmine. <em>Br J Anaesth</em>. 1999;82(1):61-65. doi:<a href="https://doi.org/10.1093/bja/82.1.61">10.1093/bja/82.1.61</a></div>
</div>
<div id="ref-Joshi1999" class="csl-entry">
<div class="csl-left-margin">41. </div><div class="csl-right-inline">Joshi GP, Garg SA, Hailey A, Yu SY. The effects of antagonizing residual neuromuscular blockade by neostigmine and glycopyrrolate on nausea and vomiting after ambulatory surgery. <em>Anesth Analg</em>. 1999;89(3):628-631. doi:<a href="https://doi.org/10.1097/00000539-199909000-00015">10.1097/00000539-199909000-00015</a></div>
</div>
<div id="ref-Lien1999" class="csl-entry">
<div class="csl-left-margin">42. </div><div class="csl-right-inline">Lien CA, Belmont MR, Wray Roth DL, Okamoto M, Abalos A, Savarese JJ. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery. <em>Anesthesiology</em>. 1999;91(1):119-126. doi:<a href="https://doi.org/10.1097/00000542-199907000-00019">10.1097/00000542-199907000-00019</a></div>
</div>
<div id="ref-McCourt1999a" class="csl-entry">
<div class="csl-left-margin">43. </div><div class="csl-right-inline">McCourt KC, Mirakhur RK, Kerr CM. Dosage of neostigmine for reversal of rocuronium block from two levels of spontaneous recovery. <em>Anaesthesia</em>. 1999;54(7):651-655. doi:<a href="https://doi.org/10.1046/j.1365-2044.1999.00893.x">10.1046/j.1365-2044.1999.00893.x</a></div>
</div>
<div id="ref-McCourt1999" class="csl-entry">
<div class="csl-left-margin">44. </div><div class="csl-right-inline">McCourt KC, Mirakhur RK, Lowry DW, Carroll MT, Sparr HJ. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with org 9487 (rapacuronium) or rocuronium following an initial dose of org 9487. <em>Br J Anaesth</em>. 1999;82(5):755-756. doi:<a href="https://doi.org/10.1093/bja/82.5.755">10.1093/bja/82.5.755</a></div>
</div>
<div id="ref-Hayes2000" class="csl-entry">
<div class="csl-left-margin">45. </div><div class="csl-right-inline">Hayes A, Breslin D, Reid J, Mirakhur RK. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine. <em>Anaesthesia</em>. 2000;55(9):859-863. doi:<a href="https://doi.org/10.1046/j.1365-2044.2000.01541.x">10.1046/j.1365-2044.2000.01541.x</a></div>
</div>
<div id="ref-Lovstad2001" class="csl-entry">
<div class="csl-left-margin">46. </div><div class="csl-right-inline">Løvstad RZ, Thagaard KS, Berner NS, Raeder JC. Neostigmine 50 microg kg(-1) with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery. <em>Acta Anaesthesiol Scand</em>. 2001;45(4):495-500. doi:<a href="https://doi.org/10.1034/j.1399-6576.2001.045004495.x">10.1034/j.1399-6576.2001.045004495.x</a></div>
</div>
<div id="ref-Kirkegaard2002" class="csl-entry">
<div class="csl-left-margin">47. </div><div class="csl-right-inline">Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. <em>Anesthesiology</em>. 2002;96(1):45-50. doi:<a href="https://doi.org/10.1097/00000542-200201000-00013">10.1097/00000542-200201000-00013</a></div>
</div>
<div id="ref-Oh2004" class="csl-entry">
<div class="csl-left-margin">48. </div><div class="csl-right-inline">Oh AY, Kim SD, Kim CS. Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. <em>Anaesth Intensive Care</em>. 2004;32(5):649-652. doi:<a href="https://doi.org/10.1177/0310057x0403200507">10.1177/0310057x0403200507</a></div>
</div>
<div id="ref-Adamus2006" class="csl-entry">
<div class="csl-left-margin">49. </div><div class="csl-right-inline">Adamus M, Belohlavek R, Koutna J, Vujcikova M, Janaskova E. Cisatracurium vs. Rocuronium: A prospective, comparative, randomized study in adult patients under total intravenous anaesthesia. <em>Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub</em>. 2006;150(2):333-338. doi:<a href="https://doi.org/10.5507/bp.2006.051">10.5507/bp.2006.051</a></div>
</div>
<div id="ref-Sorgenfrei2006" class="csl-entry">
<div class="csl-left-margin">50. </div><div class="csl-right-inline">Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: A dose-finding and safety study. <em>Anesthesiology</em>. 2006;104(4):667-674. doi:<a href="https://doi.org/10.1097/00000542-200604000-00009">10.1097/00000542-200604000-00009</a></div>
</div>
<div id="ref-Boer2007" class="csl-entry">
<div class="csl-left-margin">51. </div><div class="csl-right-inline">Boer HD e, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: A multicenter, dose-finding and safety study. <em>Anesthesiology</em>. 2007;107(2):239-244. doi:<a href="https://doi.org/10.1097/01.anes.0000270722.95764.37">10.1097/01.anes.0000270722.95764.37</a></div>
</div>
<div id="ref-Sacan2007" class="csl-entry">
<div class="csl-left-margin">52. </div><div class="csl-right-inline">Sacan O, White PF, Tufanogullari B, Klein K. Sugammadex reversal of rocuronium-induced neuromuscular blockade: A comparison with neostigmine-glycopyrrolate and edrophonium-atropine. <em>Anesth Analg</em>. 2007;104(3):569-574. doi:<a href="https://doi.org/10.1213/01.ane.0000248224.42707.48">10.1213/01.ane.0000248224.42707.48</a></div>
</div>
<div id="ref-Sparr2007" class="csl-entry">
<div class="csl-left-margin">53. </div><div class="csl-right-inline">Sparr HJ, Vermeyen KM, Beaufort AM, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: Efficacy, safety, and pharmacokinetics. <em>Anesthesiology</em>. 2007;106(5):935-943. doi:<a href="https://doi.org/10.1097/01.anes.0000265152.78943.74">10.1097/01.anes.0000265152.78943.74</a></div>
</div>
<div id="ref-Suy2007" class="csl-entry">
<div class="csl-left-margin">54. </div><div class="csl-right-inline">Suy K, Morias K, Cammu G, et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. <em>Anesthesiology</em>. 2007;106(2):283-288. doi:<a href="https://doi.org/10.1097/00000542-200702000-00016">10.1097/00000542-200702000-00016</a></div>
</div>
<div id="ref-Suzuki2007" class="csl-entry">
<div class="csl-left-margin">55. </div><div class="csl-right-inline">Suzuki T, Mizutani H, Ishikawa K, Miyake E, Saeki S, Ogawa S. Epidurally administered mepivacaine delays recovery of train-of-four ratio from vecuronium-induced neuromuscular block. <em>Br J Anaesth</em>. 2007;99(5):721-725. doi:<a href="https://doi.org/10.1093/bja/aem253">10.1093/bja/aem253</a></div>
</div>
<div id="ref-Flockton2008" class="csl-entry">
<div class="csl-left-margin">56. </div><div class="csl-right-inline">Flockton EA, Mastronardi P, Hunter JM, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. <em>Br J Anaesth</em>. 2008;100(5):622-630. doi:<a href="https://doi.org/10.1093/bja/aen037">10.1093/bja/aen037</a></div>
</div>
<div id="ref-Jones2008" class="csl-entry">
<div class="csl-left-margin">57. </div><div class="csl-right-inline">Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: A randomized comparison with neostigmine. <em>Anesthesiology</em>. 2008;109(5):816-824. doi:<a href="https://doi.org/10.1097/ALN.0b013e31818a3fee">10.1097/ALN.0b013e31818a3fee</a></div>
</div>
<div id="ref-Puhringer2008" class="csl-entry">
<div class="csl-left-margin">58. </div><div class="csl-right-inline">Pühringer FK, Rex C, Sielenkämper AW, et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: An international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. <em>Anesthesiology</em>. 2008;109(2):188-197. doi:<a href="https://doi.org/10.1097/ALN.0b013e31817f5bc7">10.1097/ALN.0b013e31817f5bc7</a></div>
</div>
<div id="ref-Tsai2008" class="csl-entry">
<div class="csl-left-margin">59. </div><div class="csl-right-inline">Tsai CC, Chung HS, Chen PL, Yu CM, Chen MS, Hong CL. Postoperative residual curarization: Clinical observation in the post-anesthesia care unit. <em>Chang Gung Med J</em>. 2008;31(4):364-368.</div>
</div>
<div id="ref-Dahl2009" class="csl-entry">
<div class="csl-left-margin">60. </div><div class="csl-right-inline">Dahl V, Pendeville PE, Hollmann MW, Heier T, Abels EA, Blobner M. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. <em>Eur J Anaesthesiol</em>. 2009;26(10):874-884. doi:<a href="https://doi.org/10.1097/EJA.0b013e32832c605b">10.1097/EJA.0b013e32832c605b</a></div>
</div>
<div id="ref-Plaud2009" class="csl-entry">
<div class="csl-left-margin">61. </div><div class="csl-right-inline">Plaud B, Meretoja O, Hofmockel R, et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. <em>Anesthesiology</em>. 2009;110(2):284-294. doi:<a href="https://doi.org/10.1097/ALN.0b013e318194caaa">10.1097/ALN.0b013e318194caaa</a></div>
</div>
<div id="ref-White2009" class="csl-entry">
<div class="csl-left-margin">62. </div><div class="csl-right-inline">White PF, Tufanogullari B, Sacan O, et al. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. <em>Anesth Analg</em>. 2009;108(3):846-851. doi:<a href="https://doi.org/10.1213/ane.0b013e31818a9932">10.1213/ane.0b013e31818a9932</a></div>
</div>
<div id="ref-Blobner2010" class="csl-entry">
<div class="csl-left-margin">63. </div><div class="csl-right-inline">Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: Results of a randomised, controlled trial. <em>Eur J Anaesthesiol</em>. 2010;27(10):874-881. doi:<a href="https://doi.org/10.1097/EJA.0b013e32833d56b7">10.1097/EJA.0b013e32833d56b7</a></div>
</div>
<div id="ref-Fuchs-Buder2010" class="csl-entry">
<div class="csl-left-margin">64. </div><div class="csl-right-inline">Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F. Antagonism of low degrees of atracurium-induced neuromuscular blockade: Dose-effect relationship for neostigmine. <em>Anesthesiology</em>. 2010;112(1):34-40. doi:<a href="https://doi.org/10.1097/ALN.0b013e3181c53863">10.1097/ALN.0b013e3181c53863</a></div>
</div>
<div id="ref-Khuenl-Brady2010" class="csl-entry">
<div class="csl-left-margin">65. </div><div class="csl-right-inline">Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: A multicenter, randomized, controlled trial. <em>Anesth Analg</em>. 2010;110(1):64-73. doi:<a href="https://doi.org/10.1213/ane.0b013e3181ac53c3">10.1213/ane.0b013e3181ac53c3</a></div>
</div>
<div id="ref-Lederer2010" class="csl-entry">
<div class="csl-left-margin">66. </div><div class="csl-right-inline">Lederer W, Reiner T, Khuenl-Brady KS. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function. <em>J Clin Anesth</em>. 2010;22(6):420-424. doi:<a href="https://doi.org/10.1016/j.jclinane.2009.10.014">10.1016/j.jclinane.2009.10.014</a></div>
</div>
<div id="ref-Lemmens2010" class="csl-entry">
<div class="csl-left-margin">67. </div><div class="csl-right-inline">Lemmens HJ, El-Orbany MI, Berry J, Morte JB, Jr. M. Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: Sugammadex versus neostigmine. <em>BMC Anesthesiol</em>. 2010;10:15. doi:<a href="https://doi.org/10.1186/1471-2253-10-15">10.1186/1471-2253-10-15</a></div>
</div>
<div id="ref-Puhringer2010" class="csl-entry">
<div class="csl-left-margin">68. </div><div class="csl-right-inline">Pühringer FK, Gordon M, Demeyer I, et al. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: A dose-response relationship. <em>Br J Anaesth</em>. 2010;105(5):610-619. doi:<a href="https://doi.org/10.1093/bja/aeq226">10.1093/bja/aeq226</a></div>
</div>
<div id="ref-Schaller2010" class="csl-entry">
<div class="csl-left-margin">69. </div><div class="csl-right-inline">Schaller SJ, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. <em>Anesthesiology</em>. 2010;113(5):1054-1060. doi:<a href="https://doi.org/10.1097/ALN.0b013e3181f4182a">10.1097/ALN.0b013e3181f4182a</a></div>
</div>
<div id="ref-Adamus2011" class="csl-entry">
<div class="csl-left-margin">70. </div><div class="csl-right-inline">Adamus M, Hrabalek L, Wanek T, Gabrhelik T, Zapletalova J. Intraoperative reversal of neuromuscular block with sugammadex or neostigmine during extreme lateral interbody fusion, a novel technique for spine surgery. <em>J Anesth</em>. 2011;25(5):716-720. doi:<a href="https://doi.org/10.1007/s00540-011-1209-1">10.1007/s00540-011-1209-1</a></div>
</div>
<div id="ref-Illman2011" class="csl-entry">
<div class="csl-left-margin">71. </div><div class="csl-right-inline">Illman HL, Laurila P, Antila H, Meretoja OA, Alahuhta S, Olkkola KT. The duration of residual neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring. <em>Anesth Analg</em>. 2011;112(1):63-68. doi:<a href="https://doi.org/10.1213/ANE.0b013e3181fdf889">10.1213/ANE.0b013e3181fdf889</a></div>
</div>
<div id="ref-Jeong2011" class="csl-entry">
<div class="csl-left-margin">72. </div><div class="csl-right-inline">Jeong SJ, Han JI, Baik HJ, Lee H, Lee GY, Kim JH. The effect of pyridostigmine on bispectral index during recovery from sevoflurane anesthesia. <em>Korean J Anesthesiol</em>. 2011;61(6):460-464. doi:<a href="https://doi.org/10.4097/kjae.2011.61.6.460">10.4097/kjae.2011.61.6.460</a></div>
</div>
<div id="ref-Sauer2011" class="csl-entry">
<div class="csl-left-margin">73. </div><div class="csl-right-inline">Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. <em>Eur J Anaesthesiol</em>. 2011;28(12):842-848. doi:<a href="https://doi.org/10.1097/EJA.0b013e328345cd11">10.1097/EJA.0b013e328345cd11</a></div>
</div>
<div id="ref-Cammu2012" class="csl-entry">
<div class="csl-left-margin">74. </div><div class="csl-right-inline">Cammu GV, Smet V, De Jongh K, Vandeput D. A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery. <em>Anaesth Intensive Care</em>. 2012;40(6):999-1006. doi:<a href="https://doi.org/10.1177/0310057x1204000611">10.1177/0310057x1204000611</a></div>
</div>
<div id="ref-Gaszynski2012" class="csl-entry">
<div class="csl-left-margin">75. </div><div class="csl-right-inline">Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia. <em>Br J Anaesth</em>. 2012;108(2):236-239. doi:<a href="https://doi.org/10.1093/bja/aer330">10.1093/bja/aer330</a></div>
</div>
<div id="ref-Geldner2012" class="csl-entry">
<div class="csl-left-margin">76. </div><div class="csl-right-inline">Geldner G, Niskanen M, Laurila P, et al. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery. <em>Anaesthesia</em>. 2012;67(9):991-998. doi:<a href="https://doi.org/10.1111/j.1365-2044.2012.07197.x">10.1111/j.1365-2044.2012.07197.x</a></div>
</div>
<div id="ref-Grosse-Sundrup2012" class="csl-entry">
<div class="csl-left-margin">77. </div><div class="csl-right-inline">Grosse-Sundrup M, Henneman JP, Sandberg WS, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: Prospective propensity score matched cohort study. <em>Bmj</em>. 2012;345:e6329. doi:<a href="https://doi.org/10.1136/bmj.e6329">10.1136/bmj.e6329</a></div>
</div>
<div id="ref-Alkenany2013" class="csl-entry">
<div class="csl-left-margin">78. </div><div class="csl-right-inline">Alkenany HM. Evaluation of cyclodextrin (sugammadex) for reversal of intense neuromuscular block of rocuronium and vecuronium, experimental and clinical studies. <em>J Egypt Soc Parasitol</em>. 2013;43(3):705-714. doi:<a href="https://doi.org/10.12816/0006427">10.12816/0006427</a></div>
</div>
<div id="ref-Carron2013" class="csl-entry">
<div class="csl-left-margin">79. </div><div class="csl-right-inline">Carron M, Veronese S, Foletto M, Ori C. Sugammadex allows fast-track bariatric surgery. <em>Obes Surg</em>. 2013;23(10):1558-1563. doi:<a href="https://doi.org/10.1007/s11695-013-0926-y">10.1007/s11695-013-0926-y</a></div>
</div>
<div id="ref-Della-Rocca2013" class="csl-entry">
<div class="csl-left-margin">80. </div><div class="csl-right-inline">Della Rocca G, Pompei L, Pagan DEPC, et al. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: A large observational study. <em>Acta Anaesthesiol Scand</em>. 2013;57(9):1138-1145. doi:<a href="https://doi.org/10.1111/aas.12155">10.1111/aas.12155</a></div>
</div>
<div id="ref-Fuchs-Buder2013" class="csl-entry">
<div class="csl-left-margin">81. </div><div class="csl-right-inline">Fuchs-Buder T, Baumann C, De Guis J, Guerci P, Meistelman C. Low-dose neostigmine to antagonise shallow atracurium neuromuscular block during inhalational anaesthesia: A randomised controlled trial. <em>Eur J Anaesthesiol</em>. 2013;30(10):594-598. doi:<a href="https://doi.org/10.1097/EJA.0b013e3283631652">10.1097/EJA.0b013e3283631652</a></div>
</div>
<div id="ref-Kotake2013" class="csl-entry">
<div class="csl-left-margin">82. </div><div class="csl-right-inline">Kotake Y, Ochiai R, Suzuki T, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. <em>Anesth Analg</em>. 2013;117(2):345-351. doi:<a href="https://doi.org/10.1213/ANE.0b013e3182999672">10.1213/ANE.0b013e3182999672</a></div>
</div>
<div id="ref-Ledowski2013" class="csl-entry">
<div class="csl-left-margin">83. </div><div class="csl-right-inline">Ledowski T, Hillyard S, O’Dea B, Archer R, Vilas-Boas F, Kyle B. Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome. <em>Indian J Anaesth</em>. 2013;57(1):46-51. doi:<a href="https://doi.org/10.4103/0019-5049.108562">10.4103/0019-5049.108562</a></div>
</div>
<div id="ref-Pongracz2013" class="csl-entry">
<div class="csl-left-margin">84. </div><div class="csl-right-inline">Pongrácz A, Szatmári S, Nemes R, Fülesdi B, Tassonyi E. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. <em>Anesthesiology</em>. 2013;119(1):36-42. doi:<a href="https://doi.org/10.1097/ALN.0b013e318297ce95">10.1097/ALN.0b013e318297ce95</a></div>
</div>
<div id="ref-Quillfeldt2013" class="csl-entry">
<div class="csl-left-margin">85. </div><div class="csl-right-inline">Quillfeldt S von, Föhre B, Andrees N, et al. Rocuronium reversed by sugammadex versus mivacurium during high-risk eye surgery: An institutional anaesthetic practice evaluation. <em>J Int Med Res</em>. 2013;41(5):1740-1751. doi:<a href="https://doi.org/10.1177/0300060513489476">10.1177/0300060513489476</a></div>
</div>
<div id="ref-Woo2013" class="csl-entry">
<div class="csl-left-margin">86. </div><div class="csl-right-inline">Woo T, Kim KS, Shim YH, et al. Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in korean patients. <em>Korean J Anesthesiol</em>. 2013;65(6):501-507. doi:<a href="https://doi.org/10.4097/kjae.2013.65.6.501">10.4097/kjae.2013.65.6.501</a></div>
</div>
<div id="ref-Amorim2014" class="csl-entry">
<div class="csl-left-margin">87. </div><div class="csl-right-inline">Amorim P, Lagarto F, Gomes B, et al. Neostigmine vs. Sugammadex: Observational cohort study comparing the quality of recovery using the postoperative quality recovery scale. <em>Acta Anaesthesiol Scand</em>. 2014;58(9):1101-1110. doi:<a href="https://doi.org/10.1111/aas.12389">10.1111/aas.12389</a></div>
</div>
<div id="ref-Ledowski2014" class="csl-entry">
<div class="csl-left-margin">88. </div><div class="csl-right-inline">Ledowski T, Falke L, Johnston F, et al. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: Sugammadex, neostigmine or no reversal. <em>Eur J Anaesthesiol</em>. 2014;31(8):423-429. doi:<a href="https://doi.org/10.1097/eja.0000000000000010">10.1097/eja.0000000000000010</a></div>
</div>
<div id="ref-Llaurado2014" class="csl-entry">
<div class="csl-left-margin">89. </div><div class="csl-right-inline">Llauradó S, Sabaté A, Ferreres E, Camprubı́ I, Cabrera A. Postoperative respiratory outcomes in laparoscopic bariatric surgery: Comparison of a prospective group of patients whose neuromuscular blockade was reverted with sugammadex and a historical one reverted with neostigmine. <em>Rev Esp Anestesiol Reanim</em>. 2014;61(10):565-570. doi:<a href="https://doi.org/10.1016/j.redar.2013.11.009">10.1016/j.redar.2013.11.009</a></div>
</div>
<div id="ref-Martini2014" class="csl-entry">
<div class="csl-left-margin">90. </div><div class="csl-right-inline">Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. <em>Br J Anaesth</em>. 2014;112(3):498-505. doi:<a href="https://doi.org/10.1093/bja/aet377">10.1093/bja/aet377</a></div>
</div>
<div id="ref-Ozgun2014" class="csl-entry">
<div class="csl-left-margin">91. </div><div class="csl-right-inline">Ozgün C, Cakan T, Baltacı B, Başar H. Comparison of reversal and adverse effects of sugammadex and combination of - anticholinergic-anticholinesterase agents in pediatric patients. <em>J Res Med Sci</em>. 2014;19(8):762-768.</div>
</div>
<div id="ref-Rahe-Meyer2014" class="csl-entry">
<div class="csl-left-margin">92. </div><div class="csl-right-inline">Rahe-Meyer N, Fennema H, Schulman S, et al. Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients. <em>Anesthesiology</em>. 2014;121(5):969-977. doi:<a href="https://doi.org/10.1097/aln.0000000000000424">10.1097/aln.0000000000000424</a></div>
</div>
<div id="ref-Wu2014" class="csl-entry">
<div class="csl-left-margin">93. </div><div class="csl-right-inline">Wu X, Oerding H, Liu J, et al. Rocuronium blockade reversal with sugammadex vs. Neostigmine: Randomized study in chinese and caucasian subjects. <em>BMC Anesthesiol</em>. 2014;14:53. doi:<a href="https://doi.org/10.1186/1471-2253-14-53">10.1186/1471-2253-14-53</a></div>
</div>
<div id="ref-Brueckmann2015" class="csl-entry">
<div class="csl-left-margin">94. </div><div class="csl-right-inline">Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: A randomized, controlled study. <em>Br J Anaesth</em>. 2015;115(5):743-751. doi:<a href="https://doi.org/10.1093/bja/aev104">10.1093/bja/aev104</a></div>
</div>
<div id="ref-Cheong2015" class="csl-entry">
<div class="csl-left-margin">95. </div><div class="csl-right-inline">Cheong SH, Ki S, Lee J, et al. The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade. <em>Korean J Anesthesiol</em>. 2015;68(6):547-555. doi:<a href="https://doi.org/10.4097/kjae.2015.68.6.547">10.4097/kjae.2015.68.6.547</a></div>
</div>
<div id="ref-Ghoneim2015" class="csl-entry">
<div class="csl-left-margin">96. </div><div class="csl-right-inline">Ghoneim AA, El Beltagy MA. Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients. <em>Saudi J Anaesth</em>. 2015;9(3):247-252. doi:<a href="https://doi.org/10.4103/1658-354x.154696">10.4103/1658-354x.154696</a></div>
</div>
<div id="ref-Karwacki2015" class="csl-entry">
<div class="csl-left-margin">97. </div><div class="csl-right-inline">Karwacki Z, Niewiadomski S, Rzaska M. The use of sugammadex for the reversal of vecuronium-induced neuromuscular block following intracranial surgery. <em>Anaesthesiol Intensive Ther</em>. 2015;47(4):297-302. doi:<a href="https://doi.org/10.5603/ait.2015.0042">10.5603/ait.2015.0042</a></div>
</div>
<div id="ref-Koyuncu2015" class="csl-entry">
<div class="csl-left-margin">98. </div><div class="csl-right-inline">Koyuncu O, Turhanoglu S, Ozbakis Akkurt C, et al. Comparison of sugammadex and conventional reversal on postoperative nausea and vomiting: A randomized, blinded trial. <em>J Clin Anesth</em>. 2015;27(1):51-56. doi:<a href="https://doi.org/10.1016/j.jclinane.2014.08.010">10.1016/j.jclinane.2014.08.010</a></div>
</div>
<div id="ref-McLean2015" class="csl-entry">
<div class="csl-left-margin">99. </div><div class="csl-right-inline">McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. <em>Anesthesiology</em>. 2015;122(6):1201-1213. doi:<a href="https://doi.org/10.1097/aln.0000000000000674">10.1097/aln.0000000000000674</a></div>
</div>
<div id="ref-Raft2015" class="csl-entry">
<div class="csl-left-margin">100. </div><div class="csl-right-inline">Raft J, Guerci P, Harter V, Fuchs-Buder T, Meistelman C. Biological evaluation of the effect of sugammadex on hemostasis and bleeding. <em>Korean J Anesthesiol</em>. 2015;68(1):17-21. doi:<a href="https://doi.org/10.4097/kjae.2015.68.1.17">10.4097/kjae.2015.68.1.17</a></div>
</div>
<div id="ref-Rahe-Meyer2015" class="csl-entry">
<div class="csl-left-margin">101. </div><div class="csl-right-inline">Rahe-Meyer N, Berger C, Wittmann M, et al. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery. <em>Anaesthesist</em>. 2015;64(7):506-512. doi:<a href="https://doi.org/10.1007/s00101-015-0048-0">10.1007/s00101-015-0048-0</a></div>
</div>
<div id="ref-Song2015" class="csl-entry">
<div class="csl-left-margin">102. </div><div class="csl-right-inline">Song IA, Seo KS, Oh AY, et al. Timing of reversal with respect to three nerve stimulator end-points from cisatracurium-induced neuromuscular block. <em>Anaesthesia</em>. 2015;70(7):797-802. doi:<a href="https://doi.org/10.1111/anae.13044">10.1111/anae.13044</a></div>
</div>
<div id="ref-Tassonyi2015" class="csl-entry">
<div class="csl-left-margin">103. </div><div class="csl-right-inline">Tassonyi E, Pongrácz A, Nemes R, Asztalos L, Lengyel S, Fülesdi B. Reversal of pipecuronium-induced moderate neuromuscular block with sugammadex in the presence of a sevoflurane anesthetic: A randomized trial. <em>Anesth Analg</em>. 2015;121(2):373-380. doi:<a href="https://doi.org/10.1213/ane.0000000000000766">10.1213/ane.0000000000000766</a></div>
</div>
<div id="ref-Unal2015" class="csl-entry">
<div class="csl-left-margin">104. </div><div class="csl-right-inline">Ünal DY, Baran İ, Mutlu M, Ural G, Akkaya T, Özlü O. Comparison of sugammadex versus neostigmine costs and respiratory complications in patients with obstructive sleep apnoea. <em>Turk J Anaesthesiol Reanim</em>. 2015;43(6):387-395. doi:<a href="https://doi.org/10.5152/tjar.2015.35682">10.5152/tjar.2015.35682</a></div>
</div>
<div id="ref-Batistaki2016" class="csl-entry">
<div class="csl-left-margin">105. </div><div class="csl-right-inline">Batistaki C, Tentes P, Deligiannidi P, Karakosta A, Florou P, Kostopanagiotou G. Residual neuromuscular blockade in a real life clinical setting: Correlation with sugammadex or neostigmine administration. <em>Minerva Anestesiol</em>. 2016;82(5):550-558.</div>
</div>
<div id="ref-Bulka2016" class="csl-entry">
<div class="csl-left-margin">106. </div><div class="csl-right-inline">Bulka CM, Terekhov MA, Martin BJ, Dmochowski RR, Hayes RM, Ehrenfeld JM. Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia. <em>Anesthesiology</em>. 2016;125(4):647-655. doi:<a href="https://doi.org/10.1097/aln.0000000000001279">10.1097/aln.0000000000001279</a></div>
</div>
<div id="ref-Carron2016" class="csl-entry">
<div class="csl-left-margin">107. </div><div class="csl-right-inline">Carron M, Baratto F, Zarantonello F, Ori C. Sugammadex for reversal of neuromuscular blockade: A retrospective analysis of clinical outcomes and cost-effectiveness in a single center. <em>Clinicoecon Outcomes Res</em>. 2016;8:43-52. doi:<a href="https://doi.org/10.2147/ceor.S100921">10.2147/ceor.S100921</a></div>
</div>
<div id="ref-De-Robertis2016" class="csl-entry">
<div class="csl-left-margin">108. </div><div class="csl-right-inline">De Robertis E, Zito Marinosci G, Romano GM, et al. The use of sugammadex for bariatric surgery: Analysis of recovery time from neuromuscular blockade and possible economic impact. <em>Clinicoecon Outcomes Res</em>. 2016;8:317-322. doi:<a href="https://doi.org/10.2147/ceor.S109951">10.2147/ceor.S109951</a></div>
</div>
<div id="ref-Hakimoglu2016" class="csl-entry">
<div class="csl-left-margin">109. </div><div class="csl-right-inline">Hakimoğlu S, Tuzcu K, Davarcı I, et al. Comparison of sugammadex and neostigmine-atropine on intraocular pressure and postoperative effects. <em>Kaohsiung J Med Sci</em>. 2016;32(2):80-85. doi:<a href="https://doi.org/10.1016/j.kjms.2016.01.009">10.1016/j.kjms.2016.01.009</a></div>
</div>
<div id="ref-Kaufhold2016" class="csl-entry">
<div class="csl-left-margin">110. </div><div class="csl-right-inline">Kaufhold N, Schaller SJ, Stäuble CG, et al. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†. <em>Br J Anaesth</em>. 2016;116(2):233-240. doi:<a href="https://doi.org/10.1093/bja/aev437">10.1093/bja/aev437</a></div>
</div>
<div id="ref-Kim2016a" class="csl-entry">
<div class="csl-left-margin">111. </div><div class="csl-right-inline">Kim E, Ryu JH, Byun SH. Effect of neuromuscular blockade reversal by pyridostigmine on spectral entropy values during recovery from desflurane anesthesia: A prospective, randomized, double-blind, controlled trial. <em>Korean J Anesthesiol</em>. 2016;69(3):227-233. doi:<a href="https://doi.org/10.4097/kjae.2016.69.3.227">10.4097/kjae.2016.69.3.227</a></div>
</div>
<div id="ref-Kim2016" class="csl-entry">
<div class="csl-left-margin">112. </div><div class="csl-right-inline">Kim KS, Oh YN, Kim TY, Oh SY, Sin YH. Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade. <em>Korean J Anesthesiol</em>. 2016;69(3):239-243. doi:<a href="https://doi.org/10.4097/kjae.2016.69.3.239">10.4097/kjae.2016.69.3.239</a></div>
</div>
<div id="ref-Martinez-Ubieto2016" class="csl-entry">
<div class="csl-left-margin">113. </div><div class="csl-right-inline">Martinez-Ubieto J, Ortega-Lucea S, Pascual-Bellosta A, et al. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex. <em>Minerva Anestesiol</em>. 2016;82(7):735-742.</div>
</div>
<div id="ref-Oh2016" class="csl-entry">
<div class="csl-left-margin">114. </div><div class="csl-right-inline">Oh CS, Rhee KY, Yoon TG, Woo NS, Hong SW, Kim SH. Postoperative delirium in elderly patients undergoing hip fracture surgery in the sugammadex era: A retrospective study. <em>Biomed Res Int</em>. 2016;2016:1054597. doi:<a href="https://doi.org/10.1155/2016/1054597">10.1155/2016/1054597</a></div>
</div>
<div id="ref-Park2016" class="csl-entry">
<div class="csl-left-margin">115. </div><div class="csl-right-inline">Park ES, Lim BG, Lee WJ, Lee IO. Sugammadex facilitates early recovery after surgery even in the absence of neuromuscular monitoring in patients undergoing laryngeal microsurgery: A single-center retrospective study. <em>BMC Anesthesiol</em>. 2016;16(1):48. doi:<a href="https://doi.org/10.1186/s12871-016-0221-2">10.1186/s12871-016-0221-2</a></div>
</div>
<div id="ref-Preault2016" class="csl-entry">
<div class="csl-left-margin">116. </div><div class="csl-right-inline">Preault A, Capron F, Chantereau C, Donati F, Dimet J. Under sevoflurane anaesthesia, a reduced dose of neostigmine can antagonize a shallow neuromuscular block: A double-blind, randomised study. <em>Anaesth Crit Care Pain Med</em>. 2016;35(4):269-273. doi:<a href="https://doi.org/10.1016/j.accpm.2015.11.008">10.1016/j.accpm.2015.11.008</a></div>
</div>
<div id="ref-Putz2016" class="csl-entry">
<div class="csl-left-margin">117. </div><div class="csl-right-inline">Putz L, Dransart C, Jamart J, Marotta ML, Delnooz G, Dubois PE. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: A randomized controlled trial. <em>J Clin Anesth</em>. 2016;35:107-113. doi:<a href="https://doi.org/10.1016/j.jclinane.2016.07.030">10.1016/j.jclinane.2016.07.030</a></div>
</div>
<div id="ref-Sen2016" class="csl-entry">
<div class="csl-left-margin">118. </div><div class="csl-right-inline">Sen A, Erdivanli B, Tomak Y, Pergel A. Reversal of neuromuscular blockade with sugammadex or neostigmine/atropine: Effect on postoperative gastrointestinal motility. <em>J Clin Anesth</em>. 2016;32:208-213. doi:<a href="https://doi.org/10.1016/j.jclinane.2016.03.010">10.1016/j.jclinane.2016.03.010</a></div>
</div>
<div id="ref-Alsaeed2017" class="csl-entry">
<div class="csl-left-margin">119. </div><div class="csl-right-inline">Alsaeed A, Bamehriz F, Eldin S, Alzahrani T, Alharbi A, Eldawlatly A. Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery. <em>Saudi J Anaesth</em>. 2017;11(3):309-311. doi:<a href="https://doi.org/10.4103/sja.SJA{\_}113{\_}17">10.4103/sja.SJA{\_}113{\_}17</a></div>
</div>
<div id="ref-Ammar2017" class="csl-entry">
<div class="csl-left-margin">120. </div><div class="csl-right-inline">Ammar AS, Mahmoud KM, Kasemy ZA. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. <em>Acta Anaesthesiol Scand</em>. 2017;61(4):374-380. doi:<a href="https://doi.org/10.1111/aas.12868">10.1111/aas.12868</a></div>
</div>
<div id="ref-Asztalos2017" class="csl-entry">
<div class="csl-left-margin">121. </div><div class="csl-right-inline">Asztalos L, Szabó-Maák Z, Gajdos A, et al. Reversal of vecuronium-induced neuromuscular blockade with low-dose sugammadex at train-of-four count of four: A randomized controlled trial. <em>Anesthesiology</em>. 2017;127(3):441-449. doi:<a href="https://doi.org/10.1097/aln.0000000000001744">10.1097/aln.0000000000001744</a></div>
</div>
<div id="ref-Belcher2017" class="csl-entry">
<div class="csl-left-margin">122. </div><div class="csl-right-inline">Belcher AW, Leung S, Cohen B, et al. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study. <em>J Clin Anesth</em>. 2017;43:33-38. doi:<a href="https://doi.org/10.1016/j.jclinane.2017.09.005">10.1016/j.jclinane.2017.09.005</a></div>
</div>
<div id="ref-Bronsert2017" class="csl-entry">
<div class="csl-left-margin">123. </div><div class="csl-right-inline">Bronsert MR, Henderson WG, Monk TG, et al. Intermediate-acting nondepolarizing neuromuscular blocking agents and risk of postoperative 30-day morbidity and mortality, and long-term survival. <em>Anesth Analg</em>. 2017;124(5):1476-1483. doi:<a href="https://doi.org/10.1213/ane.0000000000001848">10.1213/ane.0000000000001848</a></div>
</div>
<div id="ref-Choi2017" class="csl-entry">
<div class="csl-left-margin">124. </div><div class="csl-right-inline">Choi ES, Oh AY, Koo BW, et al. Comparison of reversal with neostigmine of low-dose rocuronium vs. Reversal with sugammadex of high-dose rocuronium for a short procedure. <em>Anaesthesia</em>. 2017;72(10):1185-1190. doi:<a href="https://doi.org/10.1111/anae.13894">10.1111/anae.13894</a></div>
</div>
<div id="ref-Lee2017" class="csl-entry">
<div class="csl-left-margin">125. </div><div class="csl-right-inline">Lee OH, Choi GJ, Kang H, et al. Effects of sugammadex vs. Pyridostigmine-glycopyrrolate on post-operative nausea and vomiting: Propensity score matching. <em>Acta Anaesthesiol Scand</em>. 2017;61(1):39-45. doi:<a href="https://doi.org/10.1111/aas.12813">10.1111/aas.12813</a></div>
</div>
<div id="ref-Nemes2017" class="csl-entry">
<div class="csl-left-margin">126. </div><div class="csl-right-inline">Nemes R, Fülesdi B, Pongrácz A, et al. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial. <em>Eur J Anaesthesiol</em>. 2017;34(9):609-616. doi:<a href="https://doi.org/10.1097/eja.0000000000000585">10.1097/eja.0000000000000585</a></div>
</div>
<div id="ref-P2017" class="csl-entry">
<div class="csl-left-margin">127. </div><div class="csl-right-inline">P SL, Miskan MM, Y ZC, Zaki RA. Staggering the dose of sugammadex lowers risks for severe emergence cough: A randomized control trial. <em>BMC Anesthesiol</em>. 2017;17(1):137. doi:<a href="https://doi.org/10.1186/s12871-017-0430-3">10.1186/s12871-017-0430-3</a></div>
</div>
<div id="ref-Tas-Tuna2017" class="csl-entry">
<div class="csl-left-margin">128. </div><div class="csl-right-inline">Tas Tuna A, Palabiyik O, Orhan M, Sonbahar T, Sayhan H, Tomak Y. Does sugammadex administration affect postoperative nausea and vomiting after laparoscopic cholecystectomy: A prospective, double-blind, randomized study. <em>Surg Laparosc Endosc Percutan Tech</em>. 2017;27(4):237-240. doi:<a href="https://doi.org/10.1097/sle.0000000000000439">10.1097/sle.0000000000000439</a></div>
</div>
<div id="ref-Yagan2017" class="csl-entry">
<div class="csl-left-margin">129. </div><div class="csl-right-inline">Yağan Ö, Taş N, Mutlu T, Hancı V. Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting. <em>Braz J Anesthesiol</em>. 2017;67(2):147-152. doi:<a href="https://doi.org/10.1016/j.bjane.2015.08.003">10.1016/j.bjane.2015.08.003</a></div>
</div>
<div id="ref-Abdulatif2018" class="csl-entry">
<div class="csl-left-margin">130. </div><div class="csl-right-inline">Abdulatif M, Lotfy M, Mousa M, Afifi MH, Yassen K. Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: A randomized controlled study. <em>Minerva Anestesiol</em>. 2018;84(8):929-937. doi:<a href="https://doi.org/10.23736/s0375-9393.18.12217-6">10.23736/s0375-9393.18.12217-6</a></div>
</div>
<div id="ref-Min2018" class="csl-entry">
<div class="csl-left-margin">131. </div><div class="csl-right-inline">Min KC, Woo T, Assaid C, et al. Incidence of hypersensitivity and anaphylaxis with sugammadex. <em>J Clin Anesth</em>. 2018;47:67-73. doi:<a href="https://doi.org/10.1016/j.jclinane.2018.03.018">10.1016/j.jclinane.2018.03.018</a></div>
</div>
<div id="ref-Moon2018" class="csl-entry">
<div class="csl-left-margin">132. </div><div class="csl-right-inline">Moon YJ, Kim SH, Kim JW, Lee YK, Jun IG, Hwang GS. Comparison of postoperative coagulation profiles and outcome for sugammadex versus pyridostigmine in 992 living donors after living-donor hepatectomy. <em>Medicine (Baltimore)</em>. 2018;97(11):e0129. doi:<a href="https://doi.org/10.1097/md.0000000000010129">10.1097/md.0000000000010129</a></div>
</div>
<div id="ref-Murphy2018" class="csl-entry">
<div class="csl-left-margin">133. </div><div class="csl-right-inline">Murphy GS, Szokol JW, Avram MJ, et al. Neostigmine administration after spontaneous recovery to a train-of-four ratio of 0.9 to 1.0: A randomized controlled trial of the effect on neuromuscular and clinical recovery. <em>Anesthesiology</em>. 2018;128(1):27-37. doi:<a href="https://doi.org/10.1097/aln.0000000000001893">10.1097/aln.0000000000001893</a></div>
</div>
<div id="ref-Paech2018" class="csl-entry">
<div class="csl-left-margin">134. </div><div class="csl-right-inline">Paech MJ, Kaye R, Baber C, Nathan EA. Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: A randomised controlled trial. <em>Anaesthesia</em>. 2018;73(3):340-347. doi:<a href="https://doi.org/10.1111/anae.14174">10.1111/anae.14174</a></div>
</div>
<div id="ref-Alday2019" class="csl-entry">
<div class="csl-left-margin">135. </div><div class="csl-right-inline">Alday E, Muñoz M, Planas A, Mata E, Alvarez C. Effects of neuromuscular block reversal with sugammadex versus neostigmine on postoperative respiratory outcomes after major abdominal surgery: A randomized-controlled trial. <em>Can J Anaesth</em>. 2019;66(11):1328-1337. doi:<a href="https://doi.org/10.1007/s12630-019-01419-3">10.1007/s12630-019-01419-3</a></div>
</div>
<div id="ref-Arslantas2019" class="csl-entry">
<div class="csl-left-margin">136. </div><div class="csl-right-inline">Arslantas R, Cevik BE. Retrospective investigation of grafted kidney function after reversal of neuromuscular blockade using neostigmine or sugammadex. <em>Transplant Proc</em>. 2019;51(7):2265-2267. doi:<a href="https://doi.org/10.1016/j.transproceed.2019.03.051">10.1016/j.transproceed.2019.03.051</a></div>
</div>
<div id="ref-Claroni2019" class="csl-entry">
<div class="csl-left-margin">137. </div><div class="csl-right-inline">Claroni C, Covotta M, Torregiani G, et al. Recovery from anesthesia after robotic-assisted radical cystectomy: Two different reversals of neuromuscular blockade. <em>J Clin Med</em>. 2019;8(11). doi:<a href="https://doi.org/10.3390/jcm8111774">10.3390/jcm8111774</a></div>
</div>
<div id="ref-Gaver2019" class="csl-entry">
<div class="csl-left-margin">138. </div><div class="csl-right-inline">Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children. <em>Anesth Analg</em>. 2019;129(4):1124-1129. doi:<a href="https://doi.org/10.1213/ane.0000000000004207">10.1213/ane.0000000000004207</a></div>
</div>
<div id="ref-Gunes2019" class="csl-entry">
<div class="csl-left-margin">139. </div><div class="csl-right-inline">Gunes ME, Dural AC, Akarsu C, et al. Effect of intraoperative neuromonitoring on efficacy and safety using sugammadex in thyroid surgery: Randomized clinical trial. <em>Ann Surg Treat Res</em>. 2019;97(6):282-290. doi:<a href="https://doi.org/10.4174/astr.2019.97.6.282">10.4174/astr.2019.97.6.282</a></div>
</div>
<div id="ref-Kim2019" class="csl-entry">
<div class="csl-left-margin">140. </div><div class="csl-right-inline">Kim NY, Koh JC, Lee KY, et al. Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study. <em>J Clin Anesth</em>. 2019;57:97-102. doi:<a href="https://doi.org/10.1016/j.jclinane.2019.02.014">10.1016/j.jclinane.2019.02.014</a></div>
</div>
<div id="ref-Korkmaz2019" class="csl-entry">
<div class="csl-left-margin">141. </div><div class="csl-right-inline">Korkmaz MO, Sayhan H, Guven M. Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy? <em>Saudi Med J</em>. 2019;40(9):907-913. doi:<a href="https://doi.org/10.15537/smj.2019.9.24485">10.15537/smj.2019.9.24485</a></div>
</div>
<div id="ref-Oh2019" class="csl-entry">
<div class="csl-left-margin">142. </div><div class="csl-right-inline">Oh TK, Ji E, Na HS. The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex. <em>Medicine (Baltimore)</em>. 2019;98(26):e16142. doi:<a href="https://doi.org/10.1097/md.0000000000016142">10.1097/md.0000000000016142</a></div>
</div>
<div id="ref-Oh2019a" class="csl-entry">
<div class="csl-left-margin">143. </div><div class="csl-right-inline">Oh TK, Oh AY, Ryu JH, et al. Retrospective analysis of 30-day unplanned readmission after major abdominal surgery with reversal by sugammadex or neostigmine. <em>Br J Anaesth</em>. 2019;122(3):370-378. doi:<a href="https://doi.org/10.1016/j.bja.2018.11.028">10.1016/j.bja.2018.11.028</a></div>
</div>
<div id="ref-Park2019" class="csl-entry">
<div class="csl-left-margin">144. </div><div class="csl-right-inline">Park YS, Kim J, Kim SH, et al. Comparison of recovery profiles in patients with parkinson’s disease for 2 types of neuromuscular blockade reversal agent following deep brain stimulator implantation. <em>Medicine (Baltimore)</em>. 2019;98(52):e18406. doi:<a href="https://doi.org/10.1097/md.0000000000018406">10.1097/md.0000000000018406</a></div>
</div>
<div id="ref-Quang2019" class="csl-entry">
<div class="csl-left-margin">145. </div><div class="csl-right-inline">Quang TL, Thu HNT, Quoc KN, et al. Neuromuscular blockade agents reversal with sugammadex compared to neostigmine in the living kidney donors. <em>Open Access Maced J Med Sci</em>. 2019;7(24):4420-4425. doi:<a href="https://doi.org/10.3889/oamjms.2019.874">10.3889/oamjms.2019.874</a></div>
</div>
<div id="ref-Schepens2019" class="csl-entry">
<div class="csl-left-margin">146. </div><div class="csl-right-inline">Schepens T, Janssens K, Maes S, et al. Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: A double blind prospective randomized controlled trial. <em>BMC Anesthesiol</em>. 2019;19(1):187. doi:<a href="https://doi.org/10.1186/s12871-019-0863-y">10.1186/s12871-019-0863-y</a></div>
</div>
<div id="ref-Xia2019" class="csl-entry">
<div class="csl-left-margin">147. </div><div class="csl-right-inline">Xia R, Kachru N, Tuazon DM, Bostan F, Fuentes A. Evaluation of neuromuscular blockade reversal on postoperative mechanical ventilation time in a cardiovascular surgery population. <em>J Cardiothorac Vasc Anesth</em>. 2019;33(12):3348-3357. doi:<a href="https://doi.org/10.1053/j.jvca.2019.06.025">10.1053/j.jvca.2019.06.025</a></div>
</div>
<div id="ref-Abola2020" class="csl-entry">
<div class="csl-left-margin">148. </div><div class="csl-right-inline">Abola RE, Romeiser J, Rizwan S, Lung B, Gupta R, Bennett-Guerrero E. A randomized-controlled trial of sugammadex versus neostigmine: Impact on early postoperative strength. <em>Can J Anaesth</em>. 2020;67(8):959-969. doi:<a href="https://doi.org/10.1007/s12630-020-01695-4">10.1007/s12630-020-01695-4</a></div>
</div>
<div id="ref-Arends2020" class="csl-entry">
<div class="csl-left-margin">149. </div><div class="csl-right-inline">Arends J, Hubbard R, Shafy SZ, et al. Heart rate changes following the administration of sugammadex to infants and children with comorbid cardiac, cardiovascular, and congenital heart diseases. <em>Cardiol Res</em>. 2020;11(5):274-279. doi:<a href="https://doi.org/10.14740/cr1045">10.14740/cr1045</a></div>
</div>
<div id="ref-Boggett2020" class="csl-entry">
<div class="csl-left-margin">150. </div><div class="csl-right-inline">Boggett S, Chahal R, Griffiths J, et al. A randomised controlled trial comparing deep neuromuscular blockade reversed with sugammadex with moderate neuromuscular block reversed with neostigmine. <em>Anaesthesia</em>. 2020;75(9):1153-1163. doi:<a href="https://doi.org/10.1111/anae.15094">10.1111/anae.15094</a></div>
</div>
<div id="ref-Bowdle2020" class="csl-entry">
<div class="csl-left-margin">151. </div><div class="csl-right-inline">Bowdle A, Bussey L, Michaelsen K, et al. A comparison of a prototype electromyograph vs. A mechanomyograph and an acceleromyograph for assessment of neuromuscular blockade. <em>Anaesthesia</em>. 2020;75(2):187-195. doi:<a href="https://doi.org/10.1111/anae.14872">10.1111/anae.14872</a></div>
</div>
<div id="ref-Deana2020" class="csl-entry">
<div class="csl-left-margin">152. </div><div class="csl-right-inline">Deana C, Barbariol F, D’Incà S, Pompei L, Rocca GD. SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation. <em>BMC Anesthesiol</em>. 2020;20(1):70. doi:<a href="https://doi.org/10.1186/s12871-020-00986-z">10.1186/s12871-020-00986-z</a></div>
</div>
<div id="ref-Han2020" class="csl-entry">
<div class="csl-left-margin">153. </div><div class="csl-right-inline">Han J, Ryu JH, Koo BW, Nam SW, Cho SI, Oh AY. Effects of sugammadex on post-operative pulmonary complications in laparoscopic gastrectomy: A retrospective cohort study. <em>J Clin Med</em>. 2020;9(4). doi:<a href="https://doi.org/10.3390/jcm9041232">10.3390/jcm9041232</a></div>
</div>
<div id="ref-John2020" class="csl-entry">
<div class="csl-left-margin">154. </div><div class="csl-right-inline">John J, Perry G, Perry J, et al. Impact of neostigmine and sugammadex on time to leaving the operating room in a community hospital. <em>Innov Pharm</em>. 2020;11(3). doi:<a href="https://doi.org/10.24926/iip.v11i3.3329">10.24926/iip.v11i3.3329</a></div>
</div>
<div id="ref-Kheterpal2020" class="csl-entry">
<div class="csl-left-margin">155. </div><div class="csl-right-inline">Kheterpal S, Vaughn MT, Dubovoy TZ, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): A multicenter matched cohort analysis. <em>Anesthesiology</em>. 2020;132(6):1371-1381. doi:<a href="https://doi.org/10.1097/aln.0000000000003256">10.1097/aln.0000000000003256</a></div>
</div>
<div id="ref-Krause2020" class="csl-entry">
<div class="csl-left-margin">156. </div><div class="csl-right-inline">Krause M, McWilliams SK, Bullard KJ, et al. Neostigmine versus sugammadex for reversal of neuromuscular blockade and effects on reintubation for respiratory failure or newly initiated noninvasive ventilation: An interrupted time series design. <em>Anesth Analg</em>. 2020;131(1):141-151. doi:<a href="https://doi.org/10.1213/ane.0000000000004505">10.1213/ane.0000000000004505</a></div>
</div>
<div id="ref-Lee2020" class="csl-entry">
<div class="csl-left-margin">157. </div><div class="csl-right-inline">Lee YJ, Oh AY, Koo BW, et al. Postoperative residual neuromuscular blockade after reversal based on a qualitative peripheral nerve stimulator response: A randomised controlled trial. <em>Eur J Anaesthesiol</em>. 2020;37(3):196-202. doi:<a href="https://doi.org/10.1097/eja.0000000000001157">10.1097/eja.0000000000001157</a></div>
</div>
<div id="ref-Min2020" class="csl-entry">
<div class="csl-left-margin">158. </div><div class="csl-right-inline">Min BH, Oh TK, Song IA, Jeon YT. Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: A retrospective study. <em>BMC Anesthesiol</em>. 2020;20(1):178. doi:<a href="https://doi.org/10.1186/s12871-020-01088-6">10.1186/s12871-020-01088-6</a></div>
</div>
<div id="ref-Moon2020" class="csl-entry">
<div class="csl-left-margin">159. </div><div class="csl-right-inline">Moon TS, Reznik S, Pak T, et al. Sugammadex versus neostigmine for reversal of rocuronium-induced neuromuscular blockade: A randomized, double-blinded study of thoracic surgical patients evaluating hypoxic episodes in the early postoperative period. <em>J Clin Anesth</em>. 2020;64:109804. doi:<a href="https://doi.org/10.1016/j.jclinane.2020.109804">10.1016/j.jclinane.2020.109804</a></div>
</div>
<div id="ref-Murphy2020" class="csl-entry">
<div class="csl-left-margin">160. </div><div class="csl-right-inline">Murphy GS, Avram MJ, Greenberg SB, et al. Neuromuscular and clinical recovery in thoracic surgical patients reversed with neostigmine or sugammadex. <em>Anesth Analg</em>. Published online 2020. doi:<a href="https://doi.org/10.1213/ane.0000000000005294">10.1213/ane.0000000000005294</a></div>
</div>
<div id="ref-Niu2020" class="csl-entry">
<div class="csl-left-margin">161. </div><div class="csl-right-inline">Niu L, Wang Y, Yao C, Sun Y, Yao S, Lin Y. Efficacy and safety of neuromuscular blockade in overweight patients undergoing nasopharyngeal surgery. <em>Med Sci Monit</em>. 2020;26:e926452. doi:<a href="https://doi.org/10.12659/msm.926452">10.12659/msm.926452</a></div>
</div>
<div id="ref-Orihara2020" class="csl-entry">
<div class="csl-left-margin">162. </div><div class="csl-right-inline">Orihara M, Takazawa T, Horiuchi T, et al. Comparison of incidence of anaphylaxis between sugammadex and neostigmine: A retrospective multicentre observational study. <em>Br J Anaesth</em>. 2020;124(2):154-163. doi:<a href="https://doi.org/10.1016/j.bja.2019.10.016">10.1016/j.bja.2019.10.016</a></div>
</div>
<div id="ref-Paredes2020" class="csl-entry">
<div class="csl-left-margin">163. </div><div class="csl-right-inline">Paredes S, Porter SB, Porter IE, 2nd R. Sugammadex use in patients with end-stage renal disease: A historical cohort study. <em>Can J Anaesth</em>. 2020;67(12):1789-1797. doi:<a href="https://doi.org/10.1007/s12630-020-01812-3">10.1007/s12630-020-01812-3</a></div>
</div>
<div id="ref-Shaydenfish2020" class="csl-entry">
<div class="csl-left-margin">164. </div><div class="csl-right-inline">Shaydenfish D, Scheffenbichler FT, Kelly BJ, et al. Effects of anticholinesterase reversal under general anesthesia on postoperative cardiovascular complications: A retrospective cohort study. <em>Anesth Analg</em>. 2020;130(3):685-695. doi:<a href="https://doi.org/10.1213/ane.0000000000004099">10.1213/ane.0000000000004099</a></div>
</div>
<div id="ref-Togioka2020" class="csl-entry">
<div class="csl-left-margin">165. </div><div class="csl-right-inline">Togioka BM, Yanez D, Aziz MF, Higgins JR, Tekkali P, Treggiari MM. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery. <em>Br J Anaesth</em>. 2020;124(5):553-561. doi:<a href="https://doi.org/10.1016/j.bja.2020.01.016">10.1016/j.bja.2020.01.016</a></div>
</div>
<div id="ref-Williams2020" class="csl-entry">
<div class="csl-left-margin">166. </div><div class="csl-right-inline">Williams WH, 3rd C, J. P. L, J. D. N, N. F, L. G. Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. <em>Br J Anaesth</em>. 2020;124(2):164-172. doi:<a href="https://doi.org/10.1016/j.bja.2019.09.043">10.1016/j.bja.2019.09.043</a></div>
</div>
<div id="ref-Xiaobing2020" class="csl-entry">
<div class="csl-left-margin">167. </div><div class="csl-right-inline">Xiaobing L, Yan J, Wangping Z, Rufang Z, Jia L, Rong W. Effects of sugammadex on postoperative respiratory management in children with congenital heart disease: A randomized controlled study. <em>Biomed Pharmacother</em>. 2020;127:110180. doi:<a href="https://doi.org/10.1016/j.biopha.2020.110180">10.1016/j.biopha.2020.110180</a></div>
</div>
<div id="ref-Zhu2020" class="csl-entry">
<div class="csl-left-margin">168. </div><div class="csl-right-inline">Zhu B, Sun D, Yang L, Sun Z, Feng Y, Deng C. The effects of neostigmine on postoperative cognitive function and inflammatory factors in elderly patients - a randomized trial. <em>BMC Geriatr</em>. 2020;20(1):387. doi:<a href="https://doi.org/10.1186/s12877-020-01793-4">10.1186/s12877-020-01793-4</a></div>
</div>
<div id="ref-Chang2021" class="csl-entry">
<div class="csl-left-margin">169. </div><div class="csl-right-inline">Chang HW, Lee IO, Kang H, Won YJ, Lim YS. Coagulation effect of sugammadex as determined by thromboelastography in a randomized controlled study of surgical patients. <em>Int J Med Sci</em>. 2021;18(6):1318-1324. doi:<a href="https://doi.org/10.7150/ijms.42563">10.7150/ijms.42563</a></div>
</div>
<div id="ref-Farag2021" class="csl-entry">
<div class="csl-left-margin">170. </div><div class="csl-right-inline">Farag E, Rivas E, Bravo M, et al. Sugammadex versus neostigmine for reversal of rocuronium neuromuscular block in patients having catheter-based neurointerventional procedures: A randomized trial. <em>Anesth Analg</em>. 2021;132(6):1666-1676. doi:<a href="https://doi.org/10.1213/ane.0000000000005533">10.1213/ane.0000000000005533</a></div>
</div>
<div id="ref-Han2021" class="csl-entry">
<div class="csl-left-margin">171. </div><div class="csl-right-inline">Han J, Oh AY, Jeon YT, et al. Quality of recovery after laparoscopic cholecystectomy following neuromuscular blockade reversal with neostigmine or sugammadex: A prospective, randomized, controlled trial. <em>J Clin Med</em>. 2021;10(5). doi:<a href="https://doi.org/10.3390/jcm10050938">10.3390/jcm10050938</a></div>
</div>
<div id="ref-Horrow2021" class="csl-entry">
<div class="csl-left-margin">172. </div><div class="csl-right-inline">Horrow JC, Li W, Blobner M, et al. Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: A randomized clinical trial. <em>BMC Anesthesiol</em>. 2021;21(1):62. doi:<a href="https://doi.org/10.1186/s12871-021-01278-w">10.1186/s12871-021-01278-w</a></div>
</div>
<div id="ref-Lee2021" class="csl-entry">
<div class="csl-left-margin">173. </div><div class="csl-right-inline">Lee TY, Jeong SY, Jeong JH, Kim JH, Choi SR. Comparison of postoperative pulmonary complications between sugammadex and neostigmine in lung cancer patients undergoing video-assisted thoracoscopic lobectomy: A prospective double-blinded randomized trial. <em>Anesth Pain Med (Seoul)</em>. 2021;16(1):60-67. doi:<a href="https://doi.org/10.17085/apm.20056">10.17085/apm.20056</a></div>
</div>
<div id="ref-Li2021b" class="csl-entry">
<div class="csl-left-margin">174. </div><div class="csl-right-inline">Li D, Wang Y, Zhou Y, Yin C. Efficacy and safety of sugammadex doses calculated on the basis of corrected body weight and total body weight for the reversal of deep neuromuscular blockade in morbidly obese patients. <em>J Int Med Res</em>. 2021;49(1):300060520985679. doi:<a href="https://doi.org/10.1177/0300060520985679">10.1177/0300060520985679</a></div>
</div>
<div id="ref-Li2021" class="csl-entry">
<div class="csl-left-margin">175. </div><div class="csl-right-inline">Li L, Jiang Y, Zhang W. Sugammadex for fast-track surgery in children undergoing cardiac surgery: A randomized controlled study. <em>J Cardiothorac Vasc Anesth</em>. 2021;35(5):1388-1392. doi:<a href="https://doi.org/10.1053/j.jvca.2020.08.069">10.1053/j.jvca.2020.08.069</a></div>
</div>
<div id="ref-Song2021" class="csl-entry">
<div class="csl-left-margin">176. </div><div class="csl-right-inline">Song SW, Yoo KY, Ro YS, Pyeon T, Bae HB, Kim J. Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: A retrospective observational study. <em>J Cardiothorac Surg</em>. 2021;16(1):45. doi:<a href="https://doi.org/10.1186/s13019-021-01427-9">10.1186/s13019-021-01427-9</a></div>
</div>
<div id="ref-Yu2021" class="csl-entry">
<div class="csl-left-margin">177. </div><div class="csl-right-inline">Yu J, Park JY, Lee Y, Hwang JH, Kim YK. Sugammadex versus neostigmine on postoperative pulmonary complications after robot-assisted laparoscopic prostatectomy: A propensity score-matched analysis. <em>J Anesth</em>. 2021;35(2):262-269. doi:<a href="https://doi.org/10.1007/s00540-021-02910-2">10.1007/s00540-021-02910-2</a></div>
</div>
<div id="ref-Burbridge2020" class="csl-entry">
<div class="csl-left-margin">178. </div><div class="csl-right-inline">Burbridge MA. Incidence of anaphylaxis to sugammadex in a single-center cohort of 19,821 patients. <em>Anesthesia and Analgesia</em>. Published online 2020:93-97. doi:<a href="https://doi.org/10.1213/ANE.0000000000004752">10.1213/ANE.0000000000004752</a></div>
</div>
<div id="ref-Chae2019" class="csl-entry">
<div class="csl-left-margin">179. </div><div class="csl-right-inline">Chae YJ, Joe HB, Oh J, Lee E, Yi IK. Thirty-day postoperative outcomes following sugammadex use in colorectal surgery patients: Retrospective study. <em>Journal of Clinical Medicine</em>. 2019;8(1). doi:<a href="https://doi.org/10.3390/jcm8010097">10.3390/jcm8010097</a></div>
</div>
<div id="ref-Cho2017" class="csl-entry">
<div class="csl-left-margin">180. </div><div class="csl-right-inline">Cho HC, Lee JH, Lee SC, Park SY, Rim JC, Choi SR. Use of sugammadex in lung cancer patients undergoing video-assisted thoracoscopic lobectomy. <em>Korean Journal of Anesthesiology</em>. 2017;70(4):420-425. doi:<a href="https://doi.org/10.4097/kjae.2017.70.4.420">10.4097/kjae.2017.70.4.420</a></div>
</div>
<div id="ref-Citil2019" class="csl-entry">
<div class="csl-left-margin">181. </div><div class="csl-right-inline">Çitil AB, Tuncel ZA, Yapici N, Kudsioǧlu T, Aykaç Z, Kavakli AS. Reversal of rocuronium induced neuromuscular blockade in lung resection surgery: A comparison of sugammadex and neostigmine. <em>Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi</em>. 2019;25(1):23-30. doi:<a href="https://doi.org/10.5222/GKDAD.2019.49369">10.5222/GKDAD.2019.49369</a></div>
</div>
<div id="ref-El-sayed2016" class="csl-entry">
<div class="csl-left-margin">182. </div><div class="csl-right-inline">El sayed M, Hassan S. Does sugammadex facilitate recovery after outpatient tonsillectomy in children? <em>Egyptian Journal of Anaesthesia</em>. 2016;32(4):447-450. doi:<a href="https://doi.org/10.1016/j.egja.2016.08.021">10.1016/j.egja.2016.08.021</a></div>
</div>
<div id="ref-Evron2017" class="csl-entry">
<div class="csl-left-margin">183. </div><div class="csl-right-inline">Evron S, Abelansky Y, Ezri T, Izakson A. Respiratory events with sugammadex vs. Neostigmine following laparoscopic sleeve gastrectomy: A prospective pilot study assessing neuromuscular reversal strategies. <em>Romanian Journal of Anaesthesia and Intensive Care</em>. 2017;24(2):111-114. doi:<a href="https://doi.org/10.21454/rjaic.7518.242.evr">10.21454/rjaic.7518.242.evr</a></div>
</div>
<div id="ref-Hussein2020" class="csl-entry">
<div class="csl-left-margin">184. </div><div class="csl-right-inline">Hussein A, Hegazy MM, Elramely MA, Mohamed AG. Sugammadex versus neostigmine in pediatric cancer patients undergoing outpatient surgical procedures. <em>International Journal of Research in Pharmaceutical Sciences</em>. 2020;11(2):2741-2746. doi:<a href="https://doi.org/10.26452/ijrps.v11i2.2335">10.26452/ijrps.v11i2.2335</a></div>
</div>
<div id="ref-Johnson2018" class="csl-entry">
<div class="csl-left-margin">185. </div><div class="csl-right-inline">Johnson M, Khan OA, McGlone ER, Roman AA, Qureshi JS, Kayal A. Sugammadex is associated with better respiratory recovery than neostigmine following reversal of anaesthesia-associated neuromuscular blockade in the morbidly obese patients following elective laparoscopic surgery. <em>Laparoscopic, Endoscopic, and Robotic Surgery</em>. 2018;1(2):33-36. doi:<a href="https://doi.org/10.1016/j.lers.2018.03.002">10.1016/j.lers.2018.03.002</a></div>
</div>
<div id="ref-Kim2020" class="csl-entry">
<div class="csl-left-margin">186. </div><div class="csl-right-inline">Kim JH, Lim MS, Choi JW, Kim H, Kwon YS, Lee JJ. Comparison of the effects of sugammadex, neostigmine, and pyridostigmine on postoperative nausea and vomiting: A propensity matched study of five hospitals. <em>Journal of Clinical Medicine</em>. 2020;9(11):1-11. doi:<a href="https://doi.org/10.3390/jcm9113477">10.3390/jcm9113477</a></div>
</div>
<div id="ref-Kurcaloglu2020" class="csl-entry">
<div class="csl-left-margin">187. </div><div class="csl-right-inline">Kurçaloğlu M, Sarıhasan BB, Çetinoğlu EÇ. Comparing the effects of sugammadex and neostigmine on neuromuscular block and bispectral index in recovery from intracranial mass resection operations. <em>Eastern Journal of Medicine</em>. 2020;25(3):371-377. doi:<a href="https://doi.org/10.5505/ejm.2020.99705">10.5505/ejm.2020.99705</a></div>
</div>
<div id="ref-Ledowski2021" class="csl-entry">
<div class="csl-left-margin">188. </div><div class="csl-right-inline">Ledowski T, Szabó-Maák Z, Loh PS, et al. Reversal of residual neuromuscular block with neostigmine or sugammadex and postoperative pulmonary complications: A prospective, randomised, double-blind trial in high-risk older patients. <em>British Journal of Anaesthesia</em>. Published online 2021. doi:<a href="https://doi.org/10.1016/j.bja.2021.04.026">10.1016/j.bja.2021.04.026</a></div>
</div>
<div id="ref-Li2021a" class="csl-entry">
<div class="csl-left-margin">189. </div><div class="csl-right-inline">Li G, Freundlich RE, Gupta RK, et al. Postoperative pulmonary complications’ association with sugammadex versus neostigmine: A retrospective registry analysis. <em>Anesthesiology</em>. Published online 2021:862-873. doi:<a href="https://doi.org/10.1097/ALN.0000000000003735">10.1097/ALN.0000000000003735</a></div>
</div>
<div id="ref-Mekawy2012" class="csl-entry">
<div class="csl-left-margin">190. </div><div class="csl-right-inline">Mekawy N, Fouad Ali EA. Improved recovery profiles in sinonasal surgery sugammadex: Does it have a role? <em>Egyptian Journal of Anaesthesia</em>. 2012;28(3):175-178. doi:<a href="https://doi.org/10.1016/j.egja.2011.12.007">10.1016/j.egja.2011.12.007</a></div>
</div>
<div id="ref-Motamed2021" class="csl-entry">
<div class="csl-left-margin">191. </div><div class="csl-right-inline">Motamed C, Bourgain JL. Comparison of the time to extubation and length of stay in the PACU after sugammadex and neostigmine use in two types of surgery: A monocentric retrospective analysis. <em>Journal of Clinical Medicine</em>. 2021;10(4):1-9. doi:<a href="https://doi.org/10.3390/jcm10040815">10.3390/jcm10040815</a></div>
</div>
<div id="ref-Oh2021" class="csl-entry">
<div class="csl-left-margin">192. </div><div class="csl-right-inline">Oh C, Jo Y, Sim S, et al. Post-operative respiratory outcomes associated with the use of sugammadex in laparoscopic colorectal cancer surgery: A retrospective, propensity score matched cohort study. <em>Signa Vitae</em>. 2021;17(1):117-123. doi:<a href="https://doi.org/10.22514/sv.2020.16.0116">10.22514/sv.2020.16.0116</a></div>
</div>
<div id="ref-Olesnicky2017" class="csl-entry">
<div class="csl-left-margin">193. </div><div class="csl-right-inline">Olesnicky BL, Traill C, Marroquinharris FB. The effect of routine availability of sugammadex on postoperative respiratory complications: A historical cohort study. <em>Minerva Anestesiologica</em>. 2017;83(3):248-254. doi:<a href="https://doi.org/10.23736/S0375-9393.16.11489-0">10.23736/S0375-9393.16.11489-0</a></div>
</div>
<div id="ref-Pecek2015" class="csl-entry">
<div class="csl-left-margin">194. </div><div class="csl-right-inline">Peček B, Polh D, Priman T. New way of dosing sugammadex for termination of vecuronium induced neuromuscular block. <em>Zdravniski Vestnik</em>. 2015;84(6):439-446. <a href="https://www.embase.com/search/results?subaction=viewrecord&amp;id=L605120638&amp;from=export">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L605120638&amp;from=export</a></div>
</div>
<div id="ref-Tas2015" class="csl-entry">
<div class="csl-left-margin">195. </div><div class="csl-right-inline">Taş N, Korkmaz H, Yağan Ö, Korkmaz M. Effect of sugammadex on postoperative bleeding and coagulation parameters after septoplasty: A randomized prospective study. <em>Medical Science Monitor</em>. 2015;21:2382-2386. doi:<a href="https://doi.org/10.12659/MSM.894971">10.12659/MSM.894971</a></div>
</div>
<div id="ref-Van-Dong2020" class="csl-entry">
<div class="csl-left-margin">196. </div><div class="csl-right-inline">Van Dong L, Giang NT, Luong NV, et al. Reversal of deep effect of rocuronium by sugammadex or neostigmine after abdominal laparoscopic surgery: A single center experience in vietnam. <em>Open Access Macedonian Journal of Medical Sciences</em>. 2020;8(B):295-300. doi:<a href="https://doi.org/10.3889/oamjms.2020.4236">10.3889/oamjms.2020.4236</a></div>
</div>
<div id="ref-Zhao2021" class="csl-entry">
<div class="csl-left-margin">197. </div><div class="csl-right-inline">Zhao D, Fang J, Xiong W, Lin J, Chen W, Wu C. Effects of sugammadex versus neostigmine on intraoperative coagulation profiles in patients with thyroidectomy. <em>Drug Design, Development and Therapy</em>. 2021;15:829-834. doi:<a href="https://doi.org/10.2147/DDDT.S286803">10.2147/DDDT.S286803</a></div>
</div>
<div id="ref-Sabo2011" class="csl-entry">
<div class="csl-left-margin">198. </div><div class="csl-right-inline">Sabo D, Jones RK, Berry J, et al. Residual neuromuscular blockade at extubation: A randomized comparison of sugammadex and neostigmine reversal of rocuronium-induced blockade in patients undergoing abdominal surgery. <em>Journal of Anesthesia and Clinical Research</em>. 2011;2(6). doi:<a href="https://doi.org/10.4172/2155-6148.1000140">10.4172/2155-6148.1000140</a></div>
</div>
<div id="ref-Duranteau2021" class="csl-entry">
<div class="csl-left-margin">199. </div><div class="csl-right-inline">Duranteau O, Fernandez W, Tuna T, Engelman E, Van Obbergh L, Tabolcea I. Earlier and lower dose administration of sugammadex: A randomised placebo-controlled trial. <em>European Journal of Anaesthesiology <span><span class="math inline">\(|\)</span></span> EJA</em>. 2021;38(8):865-871. doi:<a href="https://doi.org/10.1097/eja.0000000000001502">10.1097/eja.0000000000001502</a></div>
</div>
<div id="ref-Garutti2020" class="csl-entry">
<div class="csl-left-margin">200. </div><div class="csl-right-inline">Garutti I, Errando CL, Mazzinari G, et al. Spontaneous recovery of neuromuscular blockade is an independent risk factor for postoperative pulmonary complications after abdominal surgery: A secondary analysis. <em>Eur J Anaesthesiol</em>. 2020;37(3):203-211. doi:<a href="https://doi.org/10.1097/EJA.0000000000001128">10.1097/EJA.0000000000001128</a></div>
</div>
<div id="ref-Kara2014" class="csl-entry">
<div class="csl-left-margin">201. </div><div class="csl-right-inline">Kara T, Ozbagriacik O, Turk HS, et al. Sugammadex versus neostigmine in pediatric patients: A prospective randomized study. <em>Braz J Anesthesiol (English Edition)</em>. 2014;64(6):400-405. doi:<a href="https://doi.org/10.1016/j.bjane.2014.03.001">10.1016/j.bjane.2014.03.001</a></div>
</div>
<div id="ref-Rao-Kadam2018" class="csl-entry">
<div class="csl-left-margin">202. </div><div class="csl-right-inline">Rao Kadam V, Howell S. Unrestricted and restricted access to sugammadex and side effect profile in a teaching hospital centre for year 2014- database audit study. <em>Anesth Pain Med</em>. 2018;8(1):e63066. doi:<a href="https://doi.org/10.5812/aapm.63066">10.5812/aapm.63066</a></div>
</div>
<div id="ref-Suganuma2021" class="csl-entry">
<div class="csl-left-margin">203. </div><div class="csl-right-inline">Suganuma E, Ishikawa T, Kitamura Y, et al. Recovery of lower oesophageal barrier function: A pilot study comparing a mixture of atropine and neostigmine and sugammadex: A randomised controlled pilot study. <em>Eur J Anaesthesiol</em>. 2021;38(8):856-864. doi:<a href="https://doi.org/10.1097/eja.0000000000001464">10.1097/eja.0000000000001464</a></div>
</div>
<div id="ref-Castro2014" class="csl-entry">
<div class="csl-left-margin">204. </div><div class="csl-right-inline">Castro D, Leão P, Borges S, Gomes L, Pacheco M, Figueiredo P. Sugammadex reduces postoperative pain after laparoscopic bariatric surgery: A randomized trial. <em>Surg Laparosc, Endosc Percutan Tech</em>. 2014;24(5):420-423. doi:<a href="https://doi.org/10.1097/SLE.0000000000000049">10.1097/SLE.0000000000000049</a></div>
</div>
<div id="ref-El-Sherbeny2017" class="csl-entry">
<div class="csl-left-margin">205. </div><div class="csl-right-inline">El Sherbeny MA, Elrahman EAA, Kamal RK, Abozena MAM. Efficacy and safety of sugammadex in reversing nmb (rocuronium) in adults. <em>N Y Sci J</em>. 2017;10(6):22-29. doi:<a href="https://doi.org/10.7537/marsnys100617.04">10.7537/marsnys100617.04</a></div>
</div>
</div>
<br>
<p>
<button type="button" class="btn btn-default btn-workflowr btn-workflowr-sessioninfo" data-toggle="collapse" data-target="#workflowr-sessioninfo" style="display: block;">
<span class="glyphicon glyphicon-wrench" aria-hidden="true"></span> Session information
</button>
</p>
<div id="workflowr-sessioninfo" class="collapse">
<pre><code>R version 4.1.2 (2021-11-01)
Platform: x86_64-apple-darwin17.0 (64-bit)
Running under: macOS Big Sur 10.16

Matrix products: default
BLAS:   /Library/Frameworks/R.framework/Versions/4.1/Resources/lib/libRblas.0.dylib
LAPACK: /Library/Frameworks/R.framework/Versions/4.1/Resources/lib/libRlapack.dylib

locale:
[1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8

attached base packages:
[1] stats     graphics  grDevices utils     datasets  methods   base     

other attached packages:
 [1] meta_5.1-1        formattable_0.2.1 naniar_0.6.1      forcats_0.5.1    
 [5] stringr_1.4.0     dplyr_1.0.7       purrr_0.3.4       readr_2.1.1      
 [9] tidyr_1.1.4       tibble_3.1.6      ggplot2_3.3.5     tidyverse_1.3.1  
[13] Cairo_1.5-14      countrycode_1.3.0 janitor_2.1.0     kableExtra_1.3.4 

loaded via a namespace (and not attached):
 [1] nlme_3.1-153           fs_1.5.2               bit64_4.0.5           
 [4] lubridate_1.8.0        webshot_0.5.2          httr_1.4.2            
 [7] rprojroot_2.0.2        tools_4.1.2            backports_1.4.1       
[10] bslib_0.3.1            metafor_3.0-2          utf8_1.2.2            
[13] R6_2.5.1               DBI_1.1.2              colorspace_2.0-2      
[16] withr_2.4.3            tidyselect_1.1.1       rematch_1.0.1         
[19] bit_4.0.4              compiler_4.1.2         git2r_0.29.0          
[22] cli_3.1.0              rvest_1.0.2            xml2_1.3.3            
[25] sass_0.4.0             scales_1.1.1           systemfonts_1.0.3     
[28] digest_0.6.29          minqa_1.2.4            rmarkdown_2.11        
[31] svglite_2.0.0          pkgconfig_2.0.3        htmltools_0.5.2       
[34] lme4_1.1-27.1          highr_0.9              dbplyr_2.1.1          
[37] fastmap_1.1.0          htmlwidgets_1.5.4      rlang_0.4.12          
[40] readxl_1.3.1           rstudioapi_0.13.0-9000 jquerylib_0.1.4       
[43] generics_0.1.1         jsonlite_1.7.2         vroom_1.5.7           
[46] magrittr_2.0.1         Matrix_1.4-0           Rcpp_1.0.7            
[49] munsell_0.5.0          fansi_1.0.0            lifecycle_1.0.1       
[52] visdat_0.5.3           stringi_1.7.6          whisker_0.4           
[55] yaml_2.2.1             CompQuadForm_1.4.3     snakecase_0.11.0      
[58] mathjaxr_1.4-0         MASS_7.3-54            grid_4.1.2            
[61] parallel_4.1.2         promises_1.2.0.1       crayon_1.4.2          
[64] lattice_0.20-45        haven_2.4.3            splines_4.1.2         
[67] hms_1.1.1              knitr_1.37             pillar_1.6.4          
[70] boot_1.3-28            reprex_2.0.1           glue_1.6.0            
[73] evaluate_0.14          modelr_0.1.8           nloptr_1.2.2.3        
[76] vctrs_0.3.8            tzdb_0.2.0             httpuv_1.6.5          
[79] cellranger_1.1.0       gtable_0.3.0           assertthat_0.2.1      
[82] xfun_0.29              broom_0.7.11           later_1.3.0           
[85] viridisLite_0.4.0      workflowr_1.7.0        ellipsis_0.3.2        </code></pre>
</div>
</div>


<!-- Adjust MathJax settings so that all math formulae are shown using
TeX fonts only; see
https://docs.mathjax.org/en/latest/web/configuration.html. This will make
the presentation more consistent at the cost of the webpage sometimes
taking slightly longer to load. Note that this only works because the
footer is added to webpages before the MathJax javascript. -->
<script type="text/x-mathjax-config">
  MathJax.Hub.Config({
    "HTML-CSS": { availableFonts: ["TeX"] }
  });
</script>




</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2,h3",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
